<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1364630</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2024.1364630</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Psychostimulants and social behaviors</article-title>
<alt-title alt-title-type="left-running-head">Cid-Jofr&#xe9; et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2024.1364630">10.3389/fphar.2024.1364630</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cid-Jofr&#xe9;</surname>
<given-names>Valeska</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1219435/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bahamondes</surname>
<given-names>Tamara</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Z&#xfa;&#xf1;iga Correa</surname>
<given-names>Agustina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ahumada Arias</surname>
<given-names>Ival&#xfa;</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Reyes-Parada</surname>
<given-names>Miguel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/556142/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Renard</surname>
<given-names>Georgina M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/686607/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Centro de Investigaci&#xf3;n Biom&#xe9;dica y Aplicada (CIBAP)</institution>, <institution>Escuela de Medicina</institution>, <institution>Facultad de Ciencias M&#xe9;dicas</institution>, <institution>Universidad de Santiago de Chile (USACH)</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Facultad de Ciencias de la Salud</institution>, <institution>Universidad Aut&#xf3;noma de Chile</institution>, <addr-line>Talca</addr-line>, <country>Chile</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/224878/overview">M&#xf3;nica Moreira-Rodrigues</ext-link>, School of Medicine and Biomedical Sciences (ICBAS), Portugal</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/76968/overview">Alexies Dagnino-Subiabre</ext-link>, Universidad de Valparaiso, Chile</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/765258/overview">Francisco Javier Rubio</ext-link>, National Institute on Drug Abuse (NIH), United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Miguel Reyes-Parada, <email>miguel.reyes@usach.cl</email>; Georgina M. Renard, <email>georgina.renard@usach.cl</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1364630</elocation-id>
<history>
<date date-type="received">
<day>02</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Cid-Jofr&#xe9;, Bahamondes, Z&#xfa;&#xf1;iga Correa, Ahumada Arias, Reyes-Parada and Renard.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Cid-Jofr&#xe9;, Bahamondes, Z&#xfa;&#xf1;iga Correa, Ahumada Arias, Reyes-Parada and Renard</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Mounting evidence from animal models and human studies indicates that psychostimulants can significantly affect social behaviors. This is not surprising considering that the neural circuits underlying the regulation and expression of social behaviors are highly overlapped with those targeted by psychostimulants, which in most cases have strong rewarding and, consequently, addictive properties. In the present work, we provide an overview regarding the effects of illicit and prescription psychostimulants, such as cocaine, amphetamine-type stimulants, methylphenidate or modafinil, upon social behaviors such as social play, maternal behavior, aggression, pair bonding and social cognition and how psychostimulants in both animals and humans alter them. Finally, we discuss why these effects can vary depending on numerous variables such as the type of drug considered, acute <italic>versus</italic> long-term use, clinical <italic>versus</italic> recreational consumption, or the presence or absence of concomitant risk factors.</p>
</abstract>
<kwd-group>
<kwd>psychostimulants</kwd>
<kwd>social behavior</kwd>
<kwd>reward</kwd>
<kwd>amphetamine</kwd>
<kwd>methamphetamine</kwd>
<kwd>cocaine</kwd>
<kwd>modafinil</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Neuropharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>The relationship between our species and drugs is ancient (<xref ref-type="bibr" rid="B32">de Wit and Richards, 2004</xref>) and the reasons for drug use are diverse: medical purposes, sociability, relaxation, focus and work, and awakening properties, among others. In the brain there are specific nuclei that organize, activate, and modulate the procurement of natural rewards such as food, social interactions, and sex. Some of these nuclei include the ventral tegmental area (VTA), nucleus accumbens (NAc), prefrontal cortex (PFC), lateral septum (LS) and ventral pallidum (VP), and they are part of the &#x201c;reward circuitry&#x201d; or mesocorticolimbic system (<xref ref-type="bibr" rid="B56">Hyman et al., 2006</xref>; <xref ref-type="bibr" rid="B64">Koob and Volkow, 2010</xref>). Noteworthy, these brain nuclei are not only &#x201c;activated&#x201d; by natural but also by other stimuli such as drugs of abuse (<xref ref-type="bibr" rid="B136">Volkow and Morales, 2015</xref>). This activation elicits a strong relationship between the effect of the stimulus (i.e., euphoria, pleasure, better attention, or cognitive performance) and the context where it was performed (<xref ref-type="bibr" rid="B21">Berridge and Kringelbach, 2015</xref>). Therefore, there exists a learning process leading the individual to repeat the behavior. It has been suggested that one of the main features of drug addiction (drug abuse) <italic>versus</italic> recreational use is the seeking of the reward without &#x201c;liking&#x201d; it (<xref ref-type="bibr" rid="B22">Berridge and Robinson, 2016</xref>), regardless of the adverse outcomes (an impulsive and compulsive intake).</p>
<p>Dopamine (DA) projections from VTA to NAc and other limbic structures participate in two crucial features of the rewarding process: motivated behavior and reinforcement of those behaviors. These characteristics are fundamental for drug addiction (<xref ref-type="bibr" rid="B65">Koob and Volkow, 2016</xref>; <xref ref-type="bibr" rid="B135">Volkow et al., 2016</xref>).</p>
<p>Psychostimulants like cocaine, amphetamine-type stimulants, methylphenidate (MPH), modafinil (MOD) and new psychoactive substances with stimulant effects are globally used. Estimates made by the United Nations in 2019 (<xref ref-type="bibr" rid="B24">Breckenridge et al., 2019</xref>), illustrate that there are 18 million cocaine users worldwide and confiscation of psychostimulants only in the Americas is close to 1,215 tons, being cocaine, methamphetamine (MAMPH) and amphetamine (AMPH) the leading drugs, although the percentage varies among continents.</p>
<p>Psychostimulants are drugs that act on the central nervous system (CNS), increasing alertness, and arousal and causing general behavioral excitement (<xref ref-type="bibr" rid="B83">McCreary et al., 2015</xref>). Their primary mechanism of action is to enhance the activity of the three main monoamine neurotransmitters: DA, norepinephrine (NE) and/or serotonin (5-HT), which produces an intense activation of several brain pathways underpinning the aforementioned behaviors (<xref ref-type="bibr" rid="B116">Sofuoglu and Sewell, 2009</xref>). Cocaine, AMPH, MPH, MOD, and MAMPH have the DA and NE transporter (DAT and NET, respectively) as main targets, and using differential mechanisms lead to an augmentation of the extracellular levels of DA and NE in the synaptic cleft (<xref ref-type="bibr" rid="B47">Goodwin et al., 2009</xref>; <xref ref-type="bibr" rid="B127">Underhill et al., 2020</xref>). On the other hand, drugs such as 3,4-methylenedioxymethamphetamine (MDMA or ecstasy), which is not necessarily considered a typical psychostimulant, increase mainly 5-HT levels acting on the corresponding transporter (<xref ref-type="bibr" rid="B35">Dunlap et al., 2018</xref>; <xref ref-type="bibr" rid="B92">Nichols, 2022</xref>). These diverse pharmacodynamics are likely related to some controversial effects that are discussed below. Since psychostimulants can generate various neurobiological effects, they have numerous clinical uses as well (<xref ref-type="bibr" rid="B40">Faraone, 2018</xref>). Psychostimulants are used as pharmacotherapy in neuropsychiatric disorders such as narcolepsy and attention-deficit/hyperactivity disorder (ADHD) (<xref ref-type="bibr" rid="B40">Faraone, 2018</xref>), but these drugs have been used for other purposes in non-medical settings and off-label fashion especially in young populations (<xref ref-type="bibr" rid="B16">Arria and DuPont, 2010</xref>).</p>
<p>Regarding ADHD, the psychostimulants with the highest number of prescriptions are AMPH and MPH. In addition, MOD is another stimulant that has shown promising results in clinical trials in children with ADHD (<xref ref-type="bibr" rid="B111">Rugino, 2007</xref>; <xref ref-type="bibr" rid="B9">Amiri et al., 2008</xref>; <xref ref-type="bibr" rid="B45">Goez et al., 2012</xref>; <xref ref-type="bibr" rid="B14">Arnold et al., 2014</xref>; <xref ref-type="bibr" rid="B40">Faraone, 2018</xref>; <xref ref-type="bibr" rid="B26">Caldwell et al., 2020</xref>; <xref ref-type="bibr" rid="B148">Zahed et al., 2022</xref>). Different studies have reported an over-prescription and illegal use of MOD, MPH and AMPH in young healthy individuals (<xref ref-type="bibr" rid="B67">Lakhan and Kirchgessner, 2012</xref>). However, it remains unknown the effects of the illicit use of these psychostimulants after long term (<xref ref-type="bibr" rid="B30">d&#x2019;Angelo et al., 2017</xref>).</p>
<p>Considering our social nature, social interactions are regarded as natural rewards. Interactions with peers are essential for allowing allies to conform, protecting territories or relatives, pair bonding, parental and maternal care of offspring, shared foods, shelter, and more.</p>
<p>Social behaviors can be broadly defined as a modality of communication and/or interaction between two or more individuals of a given species of animals (<xref ref-type="bibr" rid="B27">Chen and Hong, 2018</xref>). Humans, as well as other species, depend on social stimuli to make decisions. Thus, for social behavior, individuals use highly complex communication methods, specie-specific sensory cues and dynamic information between conspecifics (<xref ref-type="bibr" rid="B27">Chen and Hong, 2018</xref>). These behaviors include a variety of interactions and settings like social group living, social organization, mating, parenting, aggression, social play, and others. It must be considered that different pharmacological interventions may affect social behavior performance and increase or decrease the interactions involved in them.</p>
<p>Studies in rodents using the conditioning place preference (CPP) test have demonstrated the natural tendency to seek social interactions and their reward properties (<xref ref-type="bibr" rid="B34">Douglas et al., 2004</xref>; <xref ref-type="bibr" rid="B123">Thiel et al., 2008</xref>; <xref ref-type="bibr" rid="B33">Douglas et al., 2018</xref>), both in adults and juvenile individuals. Several brain areas have been associated with social behaviors such as PFC, infralimbic cortex (IL), NAc, VTA, hippocampus (Hipp), LS and others (<xref ref-type="bibr" rid="B34">Douglas et al., 2004</xref>; <xref ref-type="bibr" rid="B117">Soli&#xe9; et al., 2022</xref>; <xref ref-type="bibr" rid="B145">Yan and Rein, 2022</xref>). Interestingly, as we mentioned, some of them are also part of the reward circuitry. Therefore, social interactions are regulated by some of the same brain regions activated by drugs of abuse (<xref ref-type="fig" rid="F1">Figure 1</xref>). Given the crucial role of social interaction in normal socio- and neuro-development (<xref ref-type="bibr" rid="B94">O&#x2019;Connell and Hofmann, 2011</xref>; <xref ref-type="bibr" rid="B49">Gunaydin et al., 2014</xref>), it is fundamental to unravel how psychostimulants might modify the relationship between reward value and social behaviors. These modifications depend on the length of drug use, dosage, and age of the first use, leading or not to drug addiction (<xref ref-type="bibr" rid="B18">Bardo et al., 2013</xref>; <xref ref-type="bibr" rid="B29">Clare et al., 2021</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic representation of brain pathways involved in social behavior and reward. Social behaviors are regulated by brain regions and connections that, to some extent, overlap to dose activated by drugs of abuse and natural reinforces (continuous arrows). Sagittal rodent brain section showing the different nuclei of the cortical mesolimbic system and their connections within the social neural circuit <bold>(A)</bold> and the reward neural circuit <bold>(B)</bold>. Ventral tegmental area (VTA), nucleus accumbens (NAc), prefrontal cortex (PFC), hi ppocampus (HIPP), bed nucleus of the stria terminalis (BNST), medial preoptic area (MPOA), cerebello (Cb), basolateral amygdala (BLA), medial amygdala (MeA), lateral hypothalamus (LH), ventral pallidum (VP), sub thalamic nucleus (STN), rostromedial tegmentum (RMTg) lateral habenula (LHb), laterodorsal tegmentum (LDT), dopamine (DA), glutamate (GLU).</p>
</caption>
<graphic xlink:href="fphar-15-1364630-g001.tif"/>
</fig>
<p>Considering that the neural circuits underlying the regulation and expression of social behaviors are highly overlapped with those targeted by psychostimulants, the aim of the present work is to give a general overview regarding the effects of illicit and prescription psychostimulants upon social behaviors in both animals and humans.</p>
</sec>
<sec id="s2">
<title>2 Social behaviors and the reward circuitry</title>
<p>The VTA is a critical brain region involved in social interaction and reward processes. DA neurons from VTA that project to NAc participate in the coding of social and non-social stimuli and this function is modulated by several neurotransmitters and neuropeptides, such as glutamate, GABA, oxytocin (OXT) and vasopressin (AVP), among others.</p>
<p>For instance, when VTA glutamatergic projections to NAc are activated, they stimulate DA release in NAc, and place preference behavior is reinforced. However, these glutamatergic projections can reinforce this behavior independently of DA release (<xref ref-type="bibr" rid="B149">Zell et al., 2020</xref>). OXT alters the readiness of the brain to orient to social stimuli via the activation of DA neurons in VTA (<xref ref-type="bibr" rid="B48">Groppe et al., 2013</xref>). Moreover, when activation occurs at this level, social interaction generates rewarding experiences by promoting prosocial behaviors (<xref ref-type="bibr" rid="B55">Hung et al., 2017</xref>). For example, it has been shown that in male Syrian hamsters there is an increase in VTA neuronal activation during social stimuli. Specifically, the number of c-Fos immunoreactive cells in the VTA of Syrian hamsters after OXT release was higher in males who experienced direct social interaction compared with socially na&#xef;ve males. This indicates that social experience enhances the response of this area to social stimuli (<xref ref-type="bibr" rid="B55">Hung et al., 2017</xref>). Another work done in Syrian hamster demonstrated that activation of the OXT receptor (OXTR), but not the vasopressin type V1a receptor (V1aR) in the VTA is crucial for the encoding of social interactions as reward (<xref ref-type="bibr" rid="B118">Song et al., 2016</xref>).</p>
<p>The VP is a GABAergic nucleus with a small population of glutamatergic projections (<xref ref-type="bibr" rid="B115">Soares-Cunha and Heinsbroek, 2023</xref>). This nucleus is part of a larger network of limbic brain areas that mediates the salience of several rewards (food, social affiliation, sex, and others) (<xref ref-type="bibr" rid="B115">Soares-Cunha and Heinsbroek, 2023</xref>). It also acts as a central point for inputs from the medial amygdala (MeA), VTA, and lateral hypothalamus (LH), among other structures, and the VP projects back to its input sources, including the NAc and VTA for reciprocal information exchange (<xref ref-type="bibr" rid="B5">Ahrens et al., 2018</xref>; <xref ref-type="bibr" rid="B150">Zhou et al., 2022</xref>).</p>
<p>Considering the multiple connections with areas related to core processes related to reward (motivation, arousal, motor control), VP is seen as a control center that regulates limbic signals and translates them into motor outcomes (<xref ref-type="bibr" rid="B97">Ottenheimer et al., 2020</xref>; <xref ref-type="bibr" rid="B115">Soares-Cunha and Heinsbroek, 2023</xref>). Regarding motivated behaviors and natural rewards, in a study using cell specific fiber photometry it was shown that inhibition of glutamatergic neurons in VP reduces the animals&#x2019; ability to detect salient stimuli, and those neurons got activated in response to several reward related stimuli (of social and non-social nature) (<xref ref-type="bibr" rid="B140">Wang et al., 2020</xref>).</p>
<p>Fiber photometry recordings revealed that VTA GABA projection neurons respond to food (reward). This response is relatively invariable (the outcome does not change as animals learn that a cue predicts reward availability) and the extent of this response is completely correlated with the size and deliciousness of the reward. Moreover, VP neurons respond to both reward consumption and seeking&#x2013;associated motor activity. Additionally, when the VTA-to-VP GABA pathway is chemogenetically stimulated, an increased activity in a portion of VP neurons responsive to reward is observed. Interestingly, this effect was shown only in those neurons related to motivated motor activity but not in those related to reward consumption (<xref ref-type="bibr" rid="B150">Zhou et al., 2022</xref>). Additionally, optogenetic stimulation of these neurons enhances the performance of freely moving mice in a cued reward task and maintains a high incentive for reward during a progressive ratio schedule of reinforcement (<xref ref-type="bibr" rid="B150">Zhou et al., 2022</xref>).</p>
<p>NAc is a significant structure of the ventral striatum involved in the responses related to reward, motivated and goal-directed behaviors, and drugs of abuse. (<xref ref-type="bibr" rid="B8">Ambroggi et al., 2011</xref>; <xref ref-type="bibr" rid="B143">West and Carelli, 2016</xref>; <xref ref-type="bibr" rid="B102">Piantadosi et al., 2018</xref>). For example, in young animals there is an increase in neuronal activity (c-Fos immunoreactivity) after social play (a motivated young social behavior) (<xref ref-type="bibr" rid="B132">van Kerkhof et al., 2014</xref>). Furthermore, GABA antagonists can modify the length of the play (<xref ref-type="bibr" rid="B131">van Kerkhof et al., 2013</xref>). In adults, sexual consummatory behavior increases DA release in NAc in males (<xref ref-type="bibr" rid="B121">Sun et al., 2018</xref>; <xref ref-type="bibr" rid="B122">Sun et al., 2020</xref>). Moreover, a study showed DA release in both na&#xef;ve and pair-bonded males in response to pups in prairie voles (<xref ref-type="bibr" rid="B69">Lei et al., 2017</xref>).</p>
<p>Altogether, these data identify the importance of DA, glutamate, and GABAergic neurons within the VP-VTA-NAc circuit in the salience, learning, and seeking of natural rewards. Furthermore, the neuronal response is in accordance with the salience magnitude of the reward, and this does not change during a cue learning protocol, reflecting the importance of VP-VTA-NAc communication on reward and motivation for both natural and artificial rewards.</p>
<p>The PFC has a complex mix of inhibitory interneurons and receives inputs from neuromodulators such as acetylcholine (ACh), DA, and OXT, being suggested as a top-down control system for decision-making, goal-directed behaviors and complex cognitive processing (<xref ref-type="bibr" rid="B87">Miller and Cohen, 2001</xref>; <xref ref-type="bibr" rid="B53">Hoover and Vertes, 2007</xref>; <xref ref-type="bibr" rid="B10">Anastasiades and Carter, 2021</xref>). Indeed, the PFC projects to several brain areas (NAc, Hipp and amygdala) that are known to influence sociability (<xref ref-type="bibr" rid="B44">Franklin et al., 2017</xref>). Lesions of regions within the PFC in rodents have demonstrated its importance in social functioning. For example, the lesion of the rat orbitofrontal cortex increases aggressive behavior (<xref ref-type="bibr" rid="B110">Rudebeck et al., 2007</xref>). Furthermore, it has been shown that, in rats, PFC was activated (c-Fos activity) during social interaction (<xref ref-type="bibr" rid="B139">Wall et al., 2012</xref>), also showing the involvement of the PFC in social behavior.</p>
<p>It has been proposed that the medial PFC (mPFC) is also pivotal for normal social behavior. A portion of mPFC neurons increases activity when social stimuli (unfamiliar mouse), but not when non-social stimuli (an object) are presented (<xref ref-type="bibr" rid="B72">Levy et al., 2019</xref>). In humans, different reports show impairments in mPFC activity and altered social behavior in individuals with autism spectrum disorder (<xref ref-type="bibr" rid="B137">von dem Hagen et al., 2013</xref>; <xref ref-type="bibr" rid="B60">Karen Pierce et al., 2004</xref>).</p>
<p>In summary, the PFC is important for generating appropriate social responses and controlling execution function, by evaluating and interpreting social information of the moment within the context of previous experiences (<xref ref-type="bibr" rid="B44">Franklin et al., 2017</xref>; <xref ref-type="bibr" rid="B72">Levy et al., 2019</xref>).</p>
</sec>
<sec id="s3">
<title>3 Psychostimulants and social behavior in animals</title>
<sec id="s3-1">
<title>3.1 Social play</title>
<p>Social play is the first non-mother directed social behavior in young animals. It is characterized by exaggerated and distinct behavioral patterns related to social, sexual, and aggressive behavior (<xref ref-type="bibr" rid="B128">Vanderschuren et al., 2016</xref>). It is part of normal social behavior and is considered an indicator of emotional wellbeing, general health, and welfare of animals (<xref ref-type="bibr" rid="B4">Ahloy-Dallaire et al., 2018</xref>). This behavior is essential for social, cognitive, emotional, and motor abilities development, having a role in the environment and social context adaptation (<xref ref-type="bibr" rid="B129">Vanderschuren et al., 1997</xref>; <xref ref-type="bibr" rid="B128">Vanderschuren et al., 2016</xref>). Social play behavior is a highly pleasurable rewarding activity, especially in young individuals (<xref ref-type="bibr" rid="B124">Trezza et al., 2010</xref>) across species. This behavior starts around weaning and continues until early adolescence (<xref ref-type="bibr" rid="B128">Vanderschuren et al., 2016</xref>), where the type of response in the play depends on age and sex (<xref ref-type="bibr" rid="B99">Pellis and Pellis, 1987</xref>; <xref ref-type="bibr" rid="B100">Pellis and Pellis, 1990</xref>).</p>
<p>In rodents, social play is also known as &#x2018;rough and tumble play or play fighting&#x2019; and it is characterized by highly physical and vigorous movement patterns between peers. In the context of juvenile rats, social play behavior can be divided into two basic components such as pouncing (interaction in which an animal nose rubs the partner&#x2019;s nape &#x201c;asking for play&#x201d;) and pinning (interaction in which an animal stands over the ventral surface of another animal &#x201c;wanting to play&#x201d;), along with grooming, chasing, and boxing (<xref ref-type="bibr" rid="B52">Homberg et al., 2007</xref>; <xref ref-type="bibr" rid="B12">Argue and McCarthy, 2015a</xref>; <xref ref-type="bibr" rid="B13">Argue and McCarthy, 2015b</xref>). Furthermore, in rodents this type of behavior is accompanied by physical, facial, and vocal (ultrasonic vocalization) signals with ludic intention (<xref ref-type="bibr" rid="B128">Vanderschuren et al., 2016</xref>).</p>
<p>Thus, social play generates emotional excitement and bonding having a neurobiological function in development. Some studies have shown how animals with play deprivation generate higher levels of anxiety (<xref ref-type="bibr" rid="B77">Lukkes et al., 2009</xref>; <xref ref-type="bibr" rid="B128">Vanderschuren et al., 2016</xref>) and hence higher sensitivity to drugs (<xref ref-type="bibr" rid="B144">Whitaker et al., 2013</xref>; <xref ref-type="bibr" rid="B70">Lesscher et al., 2015</xref>; <xref ref-type="bibr" rid="B50">Heilig et al., 2016</xref>). Play is sensitive to several factors including motivational state, isolation periods and housing conditions. For example, in young Sprague Dawley rats, different housing conditions produce high or low levels of playing, and isolation usually diminishes general social interactions in young and adult rats regardless of sex (<xref ref-type="bibr" rid="B133">Varlinskaya and Spear, 2008</xref>).</p>
<p>Psychostimulants can profoundly alter social play behavior due to their effects on brain mechanisms involved in reward (<xref ref-type="bibr" rid="B125">Trezza et al., 2014</xref>; <xref ref-type="bibr" rid="B63">Knell, 2022</xref>). For instance, AMPH, MPH, and cocaine suppress social play. It has been shown that AMPH and MPH have a suppressive effect on social play through the stimulation of &#x3b1;2 adrenoceptors but not through DA receptors (<xref ref-type="bibr" rid="B1">Achterberg et al., 2014</xref>). The inhibitory effects of MPH on social play are mediated by a distributed network of prefrontal and limbic subcortical regions involved in cognitive control and emotional processes. Thus, microinjections of MPH in the infralimbic cortex, anterior cingulate cortex, basolateral amygdala and habenula produce a decrease in social play behavior (<xref ref-type="bibr" rid="B3">Achterberg et al., 2015</xref>). The motivation for social play is mediated by DA receptors stimulation and the suppression in the expression of play is mediated by stimulation of adrenergic &#x3b1;2 receptors, suggesting that the decrease in social play behavior promoted by MPH is regulated by a network that could work in parallel (<xref ref-type="bibr" rid="B2">Achterberg et al., 2016</xref>). Besides, it has been shown that chronic treatment with MOD in pre-adolescent rats, changes dopaminergic neurotransmission in the NAc decreasing DA release induced by a depolarizing stimulus, and suggesting a decrease in the ability of rats to perceive the rewarding effects of social play (<xref ref-type="bibr" rid="B28">Cid-Jofre et al., 2021</xref>).</p>
<p>In addition, cocaine, MPH and AMPH have demonstrated to impair social play behavior when are administrated acutely (<xref ref-type="bibr" rid="B130">Vanderschuren et al., 2008</xref>; <xref ref-type="bibr" rid="B81">Manduca et al., 2016</xref>), but not after chronic MPH (<xref ref-type="bibr" rid="B23">Bolanos et al., 2003</xref>). These data suggest that the extent of psychostimulant exposure is crucial for determining behavioral and molecular outputs in the brain reward circuit such as receptor expression, second messenger signaling, transporter function, and trafficking, among others (<xref ref-type="bibr" rid="B11">Anderson and Pierce, 2005</xref>).</p>
</sec>
<sec id="s3-2">
<title>3.2 Aggression</title>
<p>Aggressive behavior is a form of social communication, used to exert control over the social environment. It is characterized by a series of specific sequenced patterns that vary across the species in terms of frequency and duration. These are usually aimed at intruders considered rivals and are meant to suppress their reproductive success (<xref ref-type="bibr" rid="B19">Bartholow, 2018</xref>).</p>
<p>Aggressive behavior can be offensive or defensive. The offensive behavior is typically displayed by the resident and is characterized by introductory and threatening demonstrations towards the intruder intended to damage him, sometimes including an attack or behaviors such as aggressive groom, charge, and chase, among others (<xref ref-type="bibr" rid="B66">Koolhaas et al., 2013</xref>). The intruder usually displays in response a defensive behavior, characterized by the lack of initiative, evade, flee, jump, and others, which can result in non-intentional damage (<xref ref-type="bibr" rid="B95">Olivier and Young, 2002</xref>; <xref ref-type="bibr" rid="B66">Koolhaas et al., 2013</xref>).</p>
<p>It is important to note that aggression and violence are not the same. Aggressive behaviors are social responses considered normal and adaptive in animals and humans. On the other hand, violence is a harmful form of offensive aggression, given that it is a form of behavior regardless of the context that may include attacks towards vulnerable body spots such as paws, belly, and throat. In contrast, the aggression is usually directed to the back and the neck, both considered non-vulnerable targets for the attack (<xref ref-type="bibr" rid="B66">Koolhaas et al., 2013</xref>). It has been shown in mice a phenomenon known as &#x201c;addiction to aggression.&#x201d; Aggression is highly sought due to its gratifying effects, despite negative consequences in the short and long term, registering high rates of relapse, which reminds some features observed in drug addiction (<xref ref-type="bibr" rid="B46">Golden et al., 2019</xref>).</p>
<p>Several studies have focused on the impact of psychostimulants on aggressive behavior. Currently, mounting evidence shows that the use of drugs like AMPH, MAMPH, and ecstasy influences aggressive behavior, whereas the effect of MOD on this type of behavior has been less studied (<xref ref-type="bibr" rid="B31">Dawe et al., 2009</xref>; <xref ref-type="bibr" rid="B78">Machalova et al., 2012</xref>). Machalova and colleagues (<xref ref-type="bibr" rid="B78">Machalova et al., 2012</xref>) showed in an animal model of social conflict interaction (agonistic behavior model), that MOD inhibits attacks in aggressive mice and increases aggression in shy mice. On the other hand, acutely administrated MAMPH in aggressive mice produces a dose-dependent inhibition of aggressive behavior and an increase in timid behavior at high doses (<xref ref-type="bibr" rid="B78">Machalova et al., 2012</xref>). Finally, when they administered MDMA, both types of mice (aggressive and shy) showed an increase in the frequency of timid displays and a decrease in aggressive behavior was observed only in aggressive mice (<xref ref-type="bibr" rid="B78">Machalova et al., 2012</xref>). Similar results have been shown in BALB/cJ mice, an animal model of ADHD and conduct disorder, where the administration of 3&#xa0;mg/kg intraperitoneal MPH produces a decrease in aggressive behavior while 10&#xa0;mg/kg increases aggression, showing a dose-dependent effect (<xref ref-type="bibr" rid="B57">Jager et al., 2019</xref>). The first studies done with AMPH showed similar results (<xref ref-type="bibr" rid="B85">Miczek, 1974</xref>; <xref ref-type="bibr" rid="B86">Miczek and Tidey, 1989</xref>). Currently, the National Institute on Drug Abuse (NIDA, USA) directly relates the chronic use of MAMPH with violent behavior (<xref ref-type="bibr" rid="B93">NIDA, 2023</xref>). However, an increase in aggression levels due to the therapeutic use of AMPH has not been reported (<xref ref-type="bibr" rid="B96">O&#x2019;Malley et al., 2022</xref>).</p>
<p>Regarding cocaine effects on aggression, controversial results have been reported. For instance, exposure to a single high dose of cocaine in adult rats produces a decrease in defensive behaviors in the resident-intruder paradigm (<xref ref-type="bibr" rid="B7">Alves et al., 2014</xref>), whereas when a social interaction test was used, the results were opposite (<xref ref-type="bibr" rid="B107">Rademacher et al., 2002</xref>). In isolated adult mice that receive cocaine in a single-binge administration, an increase in their defense behavior was observed (<xref ref-type="bibr" rid="B37">Estelles et al., 2004</xref>).</p>
<p>As indicated by the evidence, psychostimulants effects on aggressive behavior are diverse. This variability could be related to different paradigms, drug dose, age, type of administration (acute or chronic), and the specific neurobiological effects of each drug.</p>
</sec>
<sec id="s3-3">
<title>3.3 Maternal care</title>
<p>Maternal care is a complex behavior that directly influences the survival chances of the offspring (<xref ref-type="bibr" rid="B42">Fischer and O&#x2019;Connell, 2018</xref>). This behavior includes building a nest and crouching over pups to keep them warm, nursing pups to provide nutrition, grooming them, protecting them from intruders, and retrieving pups back to the nest when they become displaced. The neurobiology of maternal care has been frequently studied in rodents, since females display very well characterized maternal behaviors towards their offspring that are easily distinguished and measured (<xref ref-type="bibr" rid="B119">Stolzenberg and Mayer, 2019</xref>).</p>
<p>Maternal care is sensitive to several environmental factors such as drugs of abuse, experience, housing conditions, isolation, and pharmacological manipulations. For instance, Perry and colleagues studied the effects of 3&#xa0;days of MAMPH administration at three different doses on parental behavior in prairie voles. They found that the lowest dose (0.2&#xa0;mg/kg) was enough to reduce the contact with the pups (<xref ref-type="bibr" rid="B101">Perry et al., 2019</xref>). When MAMPH injections (5&#xa0;mg/kg) were used prenatally in pregnant rats, during the first or second half of the gestation period, several physiological and sensorimotor effects were observed in the offspring, although there were no differences in maternal behavior (<xref ref-type="bibr" rid="B80">Malinov&#xe1;-&#x160;ev&#x10d;&#xed;kov&#xe1; et al., 2014</xref>). On the other hand, repeated MPH (5&#xa0;mg/kg) exposure during the lactation period impairs both maternal and adult offspring behavior. Regarding maternal behavior, the latency of retrieving pups was increased accompanied by a lower number of dams retrieving their pups (<xref ref-type="bibr" rid="B104">Ponchio et al., 2015</xref>).</p>
<p>In an interesting study with a fostering approach, the maternal behavior in juvenile offspring that were reared by dams exposed to intermittent cocaine was poor (<xref ref-type="bibr" rid="B58">Johns et al., 2007</xref>). Besides, chronic cocaine administration twice daily to pregnant rats for the entire gestational period elicited those dams to spend significantly less time next to the pups on <italic>postpartum</italic> day 1, and at <italic>postpartum</italic> day five, pups engaged in less ultrasonic vocalizations (<xref ref-type="bibr" rid="B74">Lippard et al., 2015</xref>). In contrast, another study showed that 10&#xa0;days of cocaine administration to females prior to mating was enough to increase subsequent maternal behavior (<xref ref-type="bibr" rid="B91">Nephew and Febo, 2010</xref>). In particular, these mothers retrieved pups more quickly, spent more time taking care of the pups, and were more aggressive towards a male intruder on day 2 of lactation compared to control animals. However, no effects were observed on days 9 and 16 of lactation (<xref ref-type="bibr" rid="B91">Nephew and Febo, 2010</xref>).</p>
<p>In summary, maternal behavior is a set of complex behaviors towards pups with their survival as a major goal. As with other social behaviors, caring for pups is a rewarding experience that can be positively or negatively affected by psychostimulants.</p>
</sec>
<sec id="s3-4">
<title>3.4 Pair bonding and partner preference</title>
<p>Pair bonding is the social behavior associated with the ability to form intense and selective social attachments (pair bonds) usually, but not exclusively, related to sexual attraction and the partner preference for mating. The brain areas associated with this behavior are PFC, NAc and VP among others.</p>
<p>The rodent prairie vole (Microtus ochrogaster) is an animal widely used to study pair bonding and the effects of drugs of abuse on the neurobiological mechanisms behind this behavior. This species is highly social and monogamous (although now it is known that there are two species, one monogamous and the other promiscuous) and forms long-term and exclusive pair bonds with a partner after mating (<xref ref-type="bibr" rid="B84">McGraw and Young, 2010</xref>). In this case, preference for the partner over a stranger conspecific is considered a pair bond index and is usually measured as time or percentage of total time of close physical contact between the animals.</p>
<p>In adult prairie voles, it has been reported inhibition of partner preference after AMPH exposure in both sexes (<xref ref-type="bibr" rid="B75">Liu et al., 2010</xref>; <xref ref-type="bibr" rid="B147">Young et al., 2014</xref>). Notably, the effects of AMPH were observed exclusively on partner preference since other related behaviors such as mating frequency or locomotor activity were not affected. Studies performed in monogamous species have suggested that neuropeptides such as OXT and AVP facilitate pair bond (<xref ref-type="bibr" rid="B108">Rigney et al., 2022</xref>). For instance, it has been reported that OXT administration into the mPFC restores both partner preference and NAc DA levels, impaired by AMPH administration (<xref ref-type="bibr" rid="B147">Young et al., 2014</xref>). On the other hand, in agreement with the protective effects of social bonding on drug abuse, Liu and colleagues (<xref ref-type="bibr" rid="B76">Liu et al., 2011</xref>) have demonstrated that pair bonding prevents AMPH-induced CPP, through a D1R-mediated mechanism. Moreover, as shown in female prairie voles, AMPH exposure increases DA levels in the NAc but not in mPFC or VTA, increases D1R mRNA in the NAc and decreases D2R mRNA in VTA. These data indicate that the effects of AMPH upon pair bonding in female prairie voles exhibit nuclei and receptor specificity (<xref ref-type="bibr" rid="B146">Young et al., 2011</xref>).</p>
<p>In the same way, a study using a continuous 2 bottle choice procedure (one bottle with tap water and other bottle with MAMPH), showed that MAMPH had an inhibitory effect in partner preference, an effect that is accompanied by a decrease of OXT levels in the paraventricular nucleus of the hypothalamus (<xref ref-type="bibr" rid="B54">Hostetler et al., 2016</xref>).</p>
<p>Globally, these works highlight the profound effects of psychostimulants in pair bonding. Since, OXT modulates the DA system and the reward process, drugs acting on OXT receptors appear promising as treatments for conditions in which these behaviors are altered.</p>
<p>
<xref ref-type="table" rid="T1">Table 1</xref> summarizes the results of the studies evaluating the effects of different psychostimulants upon diverse social behaviors in animal models.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Animal research summary in social play, aggression, maternal care, pair bonding and partner preference studies&#x2a;.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Ref.</th>
<th rowspan="2" align="center">Drug</th>
<th rowspan="2" align="center">Dose</th>
<th rowspan="2" align="center">Treatment</th>
<th colspan="2" align="center">Main results reported</th>
<th rowspan="2" align="center">Important factors considered</th>
</tr>
<tr>
<th align="center">Social activities</th>
<th align="center">Neuro-chemical or &#x2013;biological mechanism shown/suggested</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="7" align="center">Social play behavior</td>
</tr>
<tr>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B1">Achterberg et al. (2014)</xref>
</td>
<td align="left">AMPH</td>
<td align="left">0.05&#x2013;0.5&#xa0;mg/kg s.c</td>
<td rowspan="2" align="left">Acute; 30min before test</td>
<td align="left">0.2 and 0.5&#xa0;mg/kg reduced play but not social exploration</td>
<td align="left">Impacts negatively on social play through &#x3b1;-2 NE but not DA receptors</td>
<td align="left">&#x2022; Male Wistar rats PND26&#x2013;28</td>
</tr>
<tr>
<td align="left">Cocaine</td>
<td align="left">0.5&#x2013;7.5&#xa0;mg/kg s.c</td>
<td align="left">5.0&#x2013;7.5&#xa0;mg/kg reduced play</td>
<td align="left">Impacts negatively on social play through simultaneous increases in DA, NE, and 5-HT neurotransmission</td>
<td align="left">&#x2022; Experimental and partner rat received the same drug treatment</td>
</tr>
<tr>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B3">Achterberg et al. (2015)</xref>
</td>
<td rowspan="2" align="left">MPH</td>
<td rowspan="2" align="left">5.0 &#xb5;g/0.3&#xa0;&#xb5;L</td>
<td rowspan="2" align="left">Acute; 5min before test days (2 sessions of social play behavior test)</td>
<td rowspan="2" align="left">Infusions in ACC, IL, BLA and habenula reduced play without affecting social exploration or locomotor activity</td>
<td rowspan="2" align="left">Authors did not use pharmacological or cellular/molecular approaches for dissecting possible underlying mechanism</td>
<td align="left">&#x2022; Male Wistar rats PND26&#x2013;27 underwent surgery</td>
</tr>
<tr>
<td align="left">&#x2022; Experimental and partner rats received infusions</td>
</tr>
<tr>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B28">Cid-Jofre et al. (2021)</xref>
</td>
<td rowspan="2" align="left">MOD</td>
<td rowspan="2" align="left">75&#xa0;mg/kg i.p</td>
<td rowspan="2" align="left">Chronic; 14 consecutive days before test (from 22 to 35 PND)</td>
<td rowspan="2" align="left">Treatment reduced play and altered their structure without affecting social exploration</td>
<td align="left">&#x2022; Reverse dialysis of 70&#xa0;mM K&#x2b; in NAc increased NAc extracellular DA in experimental animals to a lesser extent than control group</td>
<td rowspan="2" align="left">&#x2022; Male Sprague Dawley rats PND 36</td>
</tr>
<tr>
<td align="left">&#x2022; NAc D2R expression, DA and DOPAC content levels were similar in both groups</td>
</tr>
<tr>
<td rowspan="4" align="left">
<xref ref-type="bibr" rid="B130">Vanderschuren et al. (2008)</xref>
</td>
<td rowspan="4" align="left">MPH</td>
<td rowspan="4" align="left">1.0&#xa0;mg/kg s.c</td>
<td align="left">Sub-chronic; 5 consecutive days</td>
<td align="left">&#x2022; 0.3&#x2013;3.0&#xa0;mg/kg dose dependently suppressed social play, but social exploration was not affected</td>
<td rowspan="4" align="left">Reduction in social play was mediated by &#x3b1;-2 NE receptor</td>
<td rowspan="4" align="left">&#x2022; Male Wistar rats PND26&#x2013;28</td>
</tr>
<tr>
<td rowspan="3" align="left">Half of animals received 0.1 or 1.0&#xa0;mg/kg, s.c. 30min before test</td>
<td align="left">&#x2022; 0.01 and 0.1&#xa0;mg/kg did not alter pinning</td>
</tr>
<tr>
<td align="left">&#x2022; 1&#xa0;mg/kg reduced social play as a whole</td>
</tr>
<tr>
<td align="left">&#x2022; 0.3 and 3.0&#xa0;mg/kg suppressed pinning</td>
</tr>
<tr>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B81">Manduca et al. (2016)</xref>
</td>
<td rowspan="2" align="left">AMPH</td>
<td rowspan="2" align="left">0.03&#x2013;1.0 &#xb5;g/0.3&#xa0;&#xb5;L</td>
<td rowspan="2" align="left">Acute; 15min before test</td>
<td rowspan="2" align="left">&#x2022; 0.03 and 0.1 &#xb5;g/0.3&#xa0;&#xb5;L AMPH infusions increased play</td>
<td align="left">&#x2022; Direct stimulation of NAc DA receptors, either by AMPH-induced DA release or by apomorphine is necessary to increase social play in young male rats</td>
<td align="left">&#x2022; Male Wistar rats PND28 underwent surgery &#x3d; NAc</td>
</tr>
<tr>
<td align="left">&#x2022; Inhibiting DA uptake is not sufficient</td>
<td align="left">&#x2022; Experimental and partner rat received infusions</td>
</tr>
<tr>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B23">Bolanos et al. (2003)</xref>
</td>
<td rowspan="2" align="left">MPH</td>
<td rowspan="2" align="left">2.0&#xa0;mg/kg i.p</td>
<td rowspan="2" align="left">Chronic; 14 consecutive days, twice daily (PND 20 to PND 35)</td>
<td rowspan="2" align="left">&#x2022; MPH chronic treatment did not affect play in male rats</td>
<td rowspan="2" align="left">Authors did not use pharmacological or cellular/molecular approaches for dissecting possible underlying mechanism</td>
<td align="left">&#x2022; Male Sprague Dawley rats</td>
</tr>
<tr>
<td align="left">&#x2022; Social play test was carried out in PND40 (5 days after the last MPH injection)</td>
</tr>
<tr>
<td colspan="7" align="center">Aggressive behavior</td>
</tr>
<tr>
<td rowspan="8" align="left">
<xref ref-type="bibr" rid="B78">Machalova et al. (2012)</xref>
</td>
<td rowspan="2" align="left">MOD</td>
<td rowspan="2" align="left">2, 10, or 50&#xa0;mg/kg i.p</td>
<td rowspan="2" align="left">30&#xa0;min prior to test</td>
<td align="left">&#x2022; 2 and 10&#xa0;mg/kg &#x3d; decreased timid behavioral activities in timid mice</td>
<td rowspan="8" align="left">Authors did not use pharmacological or cellular/molecular approaches for dissecting possible underlying mechanism</td>
<td rowspan="2" align="left">&#x2022; Male mice of the SPF ICR outbred strain</td>
</tr>
<tr>
<td align="left">&#x2022; 50&#xa0;mg/kg &#x3d; did not change aggressive behaviors</td>
</tr>
<tr>
<td rowspan="3" align="left">MAMPH</td>
<td rowspan="3" align="left">1, 5, or 10&#xa0;mg/kg i.p</td>
<td rowspan="3" align="left">15&#xa0;min prior to test</td>
<td align="left">&#x2022; 1&#xa0;mg/kg &#x3d; reduced aggressive behavior in aggressive mice</td>
<td rowspan="6" align="left">&#x2022; Individually housed mice were divided into 2 groups based on their behavior in the control interaction: a) aggressive or b) timid</td>
</tr>
<tr>
<td align="left">&#x2022; 5 and 10&#xa0;mg/kg &#x3d; decreased aggressive and timid behavioral activities in aggressive mice</td>
</tr>
<tr>
<td align="left">&#x2022; All doses decreased sociable behavior activities in timid mice</td>
</tr>
<tr>
<td rowspan="3" align="left">MDMA</td>
<td rowspan="3" align="left">2.5,10, or 30&#xa0;mg/kg i.p</td>
<td rowspan="3" align="left">30&#xa0;min prior to test</td>
<td align="left">&#x2022; 2.5&#xa0;mg/kg &#x3d; in timid mice decreased sociable activities</td>
</tr>
<tr>
<td align="left">&#x2022; 10 and 30&#xa0;mg/kg &#x3d; . In timid mice decreased sociable activities and increased timid behavior</td>
</tr>
<tr>
<td align="left">&#x2022; All doses decreased aggressive behaviors and increase timid behaviors in aggressive mice</td>
</tr>
<tr>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B57">Jager et al. (2019)</xref>
</td>
<td rowspan="2" align="left">MPH</td>
<td rowspan="2" align="left">3 or 10&#xa0;mg/kg i.p</td>
<td rowspan="2" align="left">20&#xa0;min prior to test</td>
<td align="left">&#x2022; 3&#xa0;mg/kg &#x3d; prolonged attack latency and prevented escalation of aggression. Decreased social interaction</td>
<td rowspan="2" align="left">Authors did not use pharmacological or cellular/molecular approaches for dissecting possible underlying mechanism</td>
<td rowspan="2" align="left">&#x2022; BALB/cJ mice</td>
</tr>
<tr>
<td align="left">&#x2022; 10&#xa0;mg/kg &#x3d; increased number of bites and attacks</td>
</tr>
<tr>
<td align="left">
<xref ref-type="bibr" rid="B85">Miczek (1974)</xref>
</td>
<td align="left">AMPH</td>
<td align="left">0.05, 0.1, 0.5, 1.0&#xa0;mg/kg i.m.</td>
<td align="left">30&#xa0;min prior to test</td>
<td align="left">&#x2022; Lower doses increase aggressive behaviors and higher doses decreased them</td>
<td align="left">Authors did not use pharmacological or cellular/molecular approaches for dissecting possible underlying mechanism</td>
<td align="left">&#x2022; Sprague Dawley rats</td>
</tr>
<tr>
<td colspan="7" align="center">Maternal/Paternal care behavior</td>
</tr>
<tr>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B101">Perry et al. (2019)</xref>
</td>
<td rowspan="3" align="left">MAMPH</td>
<td rowspan="2" align="left">0, 0.2 or 2.0&#xa0;mg/kg, i.p</td>
<td rowspan="2" align="left">daily injections for 3 consecutive days</td>
<td align="left">&#x2022; 0.2&#xa0;mg/kg &#x3d; decreased maternal and paternal care</td>
<td rowspan="3" align="left">Authors did not use pharmacological or cellular/molecular approaches for dissecting possible underlying mechanism</td>
<td rowspan="2" align="left">&#x2022; Adult male and female prairie vole PND60-122</td>
</tr>
<tr>
<td align="left">&#x2022; 2.0&#xa0;mg/kg &#x3d; decreased paternal care</td>
</tr>
<tr>
<td align="left">
<xref ref-type="bibr" rid="B80">Malinov&#xe1;-&#x160;ev&#x10d;&#xed;kov&#xe1; et al. (2014)</xref>
</td>
<td align="left">5&#xa0;mg/kg s.c</td>
<td align="left">ED1-11 or ED12-22</td>
<td align="left">&#x2022; There were no differences in any of the maternal activities between treated and control dams in both periods of injection</td>
<td align="left">&#x2022; Adult albino Wistar rats</td>
</tr>
<tr>
<td align="left">
<xref ref-type="bibr" rid="B104">Ponchio et al. (2015)</xref>
</td>
<td align="left">MPH</td>
<td align="left">5&#xa0;mg/kg p.o</td>
<td align="left">LD 2&#x2013;7</td>
<td align="left">&#x2022; Decreased maternal behavior</td>
<td align="left">Levels of 5-HT were reduced in the MPH group compared to control</td>
<td align="left">&#x2022; Female Balb-c mice</td>
</tr>
<tr>
<td rowspan="3" align="left">
<xref ref-type="bibr" rid="B58">Johns et al. (2007)</xref>
</td>
<td rowspan="9" align="center">Cocaine</td>
<td align="left">CC &#x3d; GD1&#x2013;20</td>
<td align="left">Cocaine &#x3d; chronic (CC), intermittent (IC)</td>
<td align="left">&#x2022; PND28 &#x3d; maternal care was decreased in IC-treated dams</td>
<td rowspan="3" align="left">Authors did not use pharmacological or cellular/molecular approaches for dissecting possible underlying mechanism</td>
<td align="left">&#x2022; Sprague&#x2013;Dawley rats PND28 (males and females) and PND60 (males only)</td>
</tr>
<tr>
<td align="left">IC &#x3d; GD2, 3, 8, 9, 14, 15, 20 (and during <italic>postpartum</italic>)</td>
<td align="left">Saline &#x3d; chronic (CS), intermittent (IS)</td>
<td rowspan="2" align="left">&#x2022; PND60 &#x3d; maternal care was decreased in CC-treated dams</td>
<td rowspan="2" align="left">&#x2022; Cross-fostering protocol &#x3d; after parturition litters were either returned to their mothers or fostered to dams from a different group</td>
</tr>
<tr>
<td align="left">15&#xa0;mg/kg s.c</td>
<td align="left">Untreated (UN)</td>
</tr>
<tr>
<td rowspan="3" align="left">
<xref ref-type="bibr" rid="B74">Lippard et al. (2015)</xref>
</td>
<td align="left">GD 1&#x2013;20</td>
<td align="left">Cocaine &#x3d; chronic (CC)</td>
<td align="left">&#x2022; PPD1 &#x3d; CC dams spent more time on the UN and CS pup side than they spent on the CC pup side</td>
<td align="left">&#x2022; PPD 5 &#x3d; CC dams had fewer OXT (&#x2b;) cell bodies in the mPOA compared to UN dams</td>
<td align="left">&#x2022; Sprague&#x2013;Dawley rats</td>
</tr>
<tr>
<td rowspan="2" align="left">15&#xa0;mg/kg s.c</td>
<td align="left">Saline &#x3d; chronic (CS)</td>
<td rowspan="2" align="left">&#x2022; PPD5 &#x3d; CC dams spent more time on the UN pup side than did UN and CS dams. Moreover, they touched/sniffed both UN and CC pup cages for a shorter duration than did UN and CS dams</td>
<td rowspan="2" align="left">&#x2022; PPD 5 &#x3d; CC dams showed a positive relationship between n&#xb0; of OXT (&#x2b;) cell bodies and preference-like behavior. Greater OXT expression was associated with higher engagement in touch/sniff behavior depending on the pups group</td>
<td rowspan="2" align="left">&#x2022; Cross-fostering protocol &#x3d; each test dam had two pup-providers (one UN and one CC) assigned to for postpartum testing</td>
</tr>
<tr>
<td align="left">Untreated &#x3d; (UN)</td>
</tr>
<tr>
<td rowspan="3" align="left">
<xref ref-type="bibr" rid="B91">Nephew and Febo (2010)</xref>
</td>
<td rowspan="3" align="left">15&#xa0;mg/kg i.p</td>
<td rowspan="3" align="left">10-day treatment period plus at least 4 days of withdrawal</td>
<td rowspan="3" align="left">&#x2022; LD 2 &#x3d; increased maternal behavior</td>
<td rowspan="3" align="left">Authors did not use pharmacological or cellular/molecular approaches for dissecting possible underlying mechanism</td>
<td align="left">&#x2022; Long&#x2013;Evans female rats</td>
</tr>
<tr>
<td align="left">&#x2022; Saline and cocaine treatments ended 4 days prior to the mating period</td>
</tr>
<tr>
<td align="left">&#x2022; Behavioral testing at LD 2, 9, 16</td>
</tr>
<tr>
<td colspan="7" align="center">Pair bonding and partner preference</td>
</tr>
<tr>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B75">Liu et al. (2010)</xref>
</td>
<td rowspan="6" align="left">AMPH</td>
<td rowspan="2" align="left">1.0 or 5.0&#xa0;mg/kg i.p</td>
<td rowspan="6" align="left">Once per day for 3 consecutive days</td>
<td rowspan="2" align="left">&#x2022; 1.0 and 5.0&#xa0;mg/kg &#x3d; failed to show partner preferences, while not affecting mating frequency</td>
<td align="left">&#x2022; 1&#xa0;mg/kg &#x3d; increase in D1R, but not D2R, mRNA labeling within the NAc, compared to control males</td>
<td rowspan="2" align="left">&#x2022; Male prairie vole about PND 90 when tested</td>
</tr>
<tr>
<td align="left">D1R blockade in the NAc eliminated the AMPH-induced impairment of partner preference formation</td>
</tr>
<tr>
<td rowspan="4" align="left">
<xref ref-type="bibr" rid="B147">Young et al. (2014)</xref>
</td>
<td rowspan="4" align="left">0.2 or 0.5&#xa0;mg/kg i.p</td>
<td rowspan="4" align="left">&#x2022; 0.2 and 0.5&#xa0;mg/kg &#x3d; did not form partner preference, but instead form nonselective contact with the stimulus male during the partner preference test</td>
<td align="left">&#x2022; Lower OTR-ir levels in the mPFC than controls</td>
<td rowspan="4" align="left">Female prairie vole PND 90&#x2013;120 when tested</td>
</tr>
<tr>
<td align="left">&#x2022; Lower D2R-ir levels in the NAc than controls</td>
</tr>
<tr>
<td align="left">&#x2022; Higher [DA]ext in the NAc than controls</td>
</tr>
<tr>
<td align="left">&#x2022; OXT-PLC infusion restores mating and induced partner preference formation in treated subjects</td>
</tr>
<tr>
<td align="left">
<xref ref-type="bibr" rid="B54">Hostetler et al. (2016)</xref>
</td>
<td align="left">MAMPH</td>
<td align="left">100&#xa0;mg/L in tap water</td>
<td align="left">18&#xa0;h/day for 3 consecutive days</td>
<td align="left">&#x2022; Treatment decreased partner preference</td>
<td align="left">Fewer OXT (&#x2b;) but not AVP(&#x2b;) cells in the PVN of treated animals than controls</td>
<td align="left">&#x2022; Male and female prairie voles PND 60&#x2013;120</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2a;For methodological details see the original study.</p>
</fn>
<fn>
<p>AMPH, amphetamine; MPH, methylphenidate; MOD, modafinil; MAMPH, methamphetamine; MDMA, methylenedioximethamphetamine; DA, dopamine; NE, norepinephrine; 5-HT, serotonin; DOPAC, 3,4-Dihydroxyphenylacetic acid; ED, embryonic day; LD, lactation day; GD, gestation day; s.c. &#x3d; subcutaneously; i.p. &#x3d; intraperitoneal<italic>;</italic> p.o. &#x3d; pers ors; i.m. &#x3d; intramuscular<italic>;</italic> PPD, <italic>postpartum</italic> day; PND, post-natal day; ACC, anterior cingulate cortex; IL, infralimbic cortex; mPFC, medial prefrontal cortex; mPOA , medial preoptic area; NAc, nucleus accumbens; BLA, basolateral amygdala; PVN, paraventricular nucleus; OXT, oxytocin; AVP, vasopressin.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s4">
<title>4 Psychostimulants and social behaviors in humans</title>
<p>Psychostimulants could also affect human social skills and behavior (<xref ref-type="bibr" rid="B51">Henry et al., 2009</xref>; <xref ref-type="bibr" rid="B43">Fox et al., 2011</xref>; <xref ref-type="bibr" rid="B90">Morgan and Marshall, 2013</xref>; <xref ref-type="bibr" rid="B105">Preller et al., 2014</xref>; <xref ref-type="bibr" rid="B114">Shreffler et al., 2022</xref>). However, as seen with animal models, the effects of psychostimulants upon social behavior can be controversial and even opposite depending on the type of drug analyzed, whether they are used in clinical or recreational/abuse contexts, the time of use, the age of the user, etc. Thus, for example, it has been shown that in general terms, chronic psychostimulant (e.g., cocaine or MAMPH) abusers tend to have some impairment in key social skills (<xref ref-type="bibr" rid="B51">Henry et al., 2009</xref>; <xref ref-type="bibr" rid="B43">Fox et al., 2011</xref>; <xref ref-type="bibr" rid="B90">Morgan and Marshall, 2013</xref>; <xref ref-type="bibr" rid="B105">Preller et al., 2014</xref>; <xref ref-type="bibr" rid="B114">Shreffler et al., 2022</xref>) and reduced social networks, and also show a series of alterations in brain networks underlying social behaviors (see, for example, (<xref ref-type="bibr" rid="B15">Aron and Paulus, 2007</xref>; <xref ref-type="bibr" rid="B89">Monterosso et al., 2007</xref>; <xref ref-type="bibr" rid="B61">Kim et al., 2010</xref>; <xref ref-type="bibr" rid="B79">Mackey and Paulus, 2013</xref>)).In contrast, patients using psychostimulants in clinical settings (e.g., MPH for the treatment of ADHD) exhibit improvements in some of the same aforementioned social skills (<xref ref-type="bibr" rid="B39">Fantozzi et al., 2021a</xref>; <xref ref-type="bibr" rid="B38">Fantozzi et al., 2021b</xref>; <xref ref-type="bibr" rid="B71">Levi-Shachar et al., 2021</xref>). Beyond these global considerations, most of the reports highlight that there is a lack of research in humans regarding psychostimulants and social behaviors since the majority of the works are related to their physiological effects, addictive properties, and potential treatments for their abuse. Here, we give an overview of some recent studies that show a relationship between psychostimulant consumption and modifications in sociality, empathy and aggression in humans.</p>
<sec id="s4-1">
<title>4.1 Pro sociality and empathy</title>
<p>One of the most studied drugs in relation with social behavior is MDMA. In 2012, MDMA was estimated to be the 3rd recreational drug among adults (between 18 and 25&#xa0;years old) and in the same year, nearly 869,000 consumed it for the first time in the USA (<xref ref-type="bibr" rid="B120">Substance Abuse and Mental Health Services Administration, 2014</xref>). In addition, MDMA is under examination as a potential counterpart for psychotherapy (<xref ref-type="bibr" rid="B41">Feduccia et al., 2023</xref>; <xref ref-type="bibr" rid="B59">Kangaslampi and Zijlmans, 2023</xref>). In various reports it has been described that MDMA has a prosocial effect. For instance, Wardle and de Wit (<xref ref-type="bibr" rid="B141">Wardle and de Wit, 2014</xref>) analyzed the effects of MDMA using a three-session within-subjects design over 36 healthy volunteers of both sexes. In females only, MDMA (1.5&#xa0;mg/kg) both increased smiling (zygomatic muscle activity) and reduced frown (corrugator muscle activity) in response to happy facial expressions, indicating more positive reactions to positive facial expressions. Therefore, MDMA altered emotional perception processing and response. It also impacts behavior and perception in an actual social scenario with a partner (<xref ref-type="bibr" rid="B141">Wardle and de Wit, 2014</xref>).</p>
<p>In a non-social and controlled laboratory setup, the administration of MDMA (from 0.5 to 2.0&#xa0;mg/kg) increased (relative to placebo) self-report ratings of a broad range of socially relevant mood states. In this line, there is some evidence suggesting that MDMA prosocial effect depends on the social setting used in research. When MDMA (1.0&#xa0;mg/kg single administration) was analyzed in volunteers, the increased feelings of confidence only appeared in subjects that were accompanied by other participants (exposed to MDMA too) (<xref ref-type="bibr" rid="B62">Kirkpatrick and de Wit, 2015</xref>). Interestingly, MDMA (0.75&#xa0;mg/kg) increased the rating of loneliness (<xref ref-type="bibr" rid="B20">Bedi et al., 2010</xref>) in individuals who received the drug alone in isolated laboratory setups. In a study of free speech, MDMA increased the use of social and sexual words, as well as words referring to death, (<xref ref-type="bibr" rid="B17">Baggott et al., 2015</xref>), suggesting that consequences on speech reflect underlying alterations in social mood states. Thus, these findings suggest that MDMA generates prosocial feelings and different mental states in humans in controlled laboratory conditions that depend on social settings.</p>
<p>Studying several domains of social cognition in cocaine, MAMPH, and non-medical MPH users, interesting results have been described. For instance, a negative impact in the total performance for emotion cognition was observed only in MAMPH users. For emotional empathy, cocaine and MAMPH score lower than controls. Regarding cocaine users they show decreased social and moral decision-making, and lower social reward compared to controls [reviewed in (<xref ref-type="bibr" rid="B106">Quednow, 2017</xref>). As we mentioned previously, social network size is influenced by psychostimulant abuse. In both cases, cocaine and MPH users exhibit smaller social networks (<xref ref-type="bibr" rid="B106">Quednow, 2017</xref>).</p>
<p>More recently, social decision-making was analyzed in males with MAMPH use disorder. Applying a modified dictator monetary game where two scenarios were present (disadvantageous and advantageous), the pro-sociality behavior was measured. If the subject chose no money or less money for themselves against the hypothetical strangers, the choice was selected as pro-social. In the disadvantageous context, males with MAMPH use disorder made fewer pro-social choices compared to controls, however, in the advantageous context authors reported no differences in pro-social choices between groups (<xref ref-type="bibr" rid="B73">Li et al., 2022</xref>). Although the pro-social decisions could be different if the interaction were face to face, this study suggests that in disadvantageous scenarios MAMPH male users have less consideration of other&#x2019;s benefits as compared to healthy controls.</p>
<p>On the other hand, there is evidence that ADHD patients have some problems with emotion recognition and social skills. MPH is the first-line medication for this disorder and several works have studied the effect of the drug on different aspects of social performance. Alkalay and Dan (<xref ref-type="bibr" rid="B6">Alkalay and Dan, 2022</xref>), after reviewing 15 studies on the impact of MPH on social performance in children between 6 and 14&#xa0;years old with ADHD, concluded that MPH seems to improve the social deficit after weeks of treatment, increasing the capacity to recognize emotions and decreasing conflictive behaviors. However, as mentioned, these authors recognize that still controversial results exist and further studies are required to confirm conclusions.</p>
<p>On the other hand, the administration of lisdexamphetamine (LDX) to parents diagnosed with ADHD improved parenting behaviors. The pharmacological intervention reduced ADHD symptoms -negative talk during free play and quiet time components. Also, parents treated with LDX made over four times more praising statements, reduced their number of verbalizations during the homework task, and reduced the percentage of demands during tasks (<xref ref-type="bibr" rid="B142">Waxmonsky et al., 2014</xref>).</p>
</sec>
<sec id="s4-2">
<title>4.2 Aggressive behavior</title>
<p>High aggression is a problematic social behavior that can be explained, among other causes, by a deficit of social cognition skills that could be impaired by the use of drugs. Impulsivity, a characteristic related to drug abuse, has also been associated with aggressive behaviors. In addition, although not well studied, the use of psychostimulants seems to be a cause of aggression. A study performed in medical students assessed the relationship between the use of psychostimulants for non-medical reasons and aggressive-hostility behavior. The study was carried out using a 73-question anonymous survey that included the Zuckerman&#x2013;Kuhlman Personality Questionnaire in which aggressive behavior is described as a &#x201c;tendency to express verbal aggression and show rudeness&#x201d; among other qualities such as &#x201c;thoughtlessness, vengefulness, spitefulness, quick temper and impatient behavior.&#x201d; Results showed that the use of psychostimulants is related to aggressive behavior at least in this student sample (<xref ref-type="bibr" rid="B25">Bucher et al., 2013</xref>).</p>
<p>Among psychostimulants, several studies have shown that the use of amphetamine-related drugs, in particular MAMPH, increases aggressive behaviors or trait aggression (<xref ref-type="bibr" rid="B113">Sekine et al., 2006</xref>; <xref ref-type="bibr" rid="B103">Pl&#xfc;ddemann et al., 2010</xref>; <xref ref-type="bibr" rid="B98">Payer et al., 2012</xref>; <xref ref-type="bibr" rid="B68">Lederer et al., 2016</xref>). A study assessed the magnitude of deficit in social cognition skills and its relation with aggression in MAMPH dependent individuals, compared with MAMPH users with psychosis and a control group. The criteria used were the facial morphing &#x201c;emotion recognition task&#x201d; with emotions such as anger, fear, happiness, and sadness, the &#x201c;reading the mind in the eyes task&#x201d; and the aggression questionnaire. The MAMPH dependent groups showed impairment in social cognition skills and higher levels of aggression, although there were no associations between them (<xref ref-type="bibr" rid="B126">Uhlmann et al., 2018</xref>).</p>
<p>Although it is well known that the use of MAMPH increases aggression, little is known about the underlying biological mechanisms. It has been shown that MAMPH withdrawal increases aggressive levels and decreases the expression of serotonin transporters in several brain regions like the midbrain, striatum and cortex (<xref ref-type="bibr" rid="B113">Sekine et al., 2006</xref>). Other studies have shown that MAMPH dependent individuals exhibiting higher aggression levels also showed higher activity in PFC and occipital cortex (<xref ref-type="bibr" rid="B98">Payer et al., 2012</xref>) and a decrease of frontal white matter (<xref ref-type="bibr" rid="B68">Lederer et al., 2016</xref>). Altogether these results suggest that MAMPH abuse increases aggression due to, at least in part, the alteration in frontal cortex functions.</p>
<p>The use of alcohol is related to aggression, and on many occasions people combine the use of alcohol with other drugs. It has been shown that in amphetamine-type stimulant users, the combination with alcohol increases aggression and hostility only in MAMPH users but not in those who combine alcohol with MDMA (<xref ref-type="bibr" rid="B36">EllenLeslie et al., 2017</xref>). Another risk factor that could increase aggressive behavior in MAMPH users is post-traumatic stress disorder (<xref ref-type="bibr" rid="B138">Wahlstrom et al., 2015</xref>). These results highlight the importance of different risk factors that could increase the levels of aggression in psychostimulant users.</p>
<p>Regarding cocaine, less is known about the relationship between this drug and aggression. In a 2002 study, Moeller and colleagues (<xref ref-type="bibr" rid="B88">Moeller et al., 2002</xref>) investigated the effects of cocaine on impulsivity. In brief, impulsivity was measured in both cocaine dependent subjects and controls using an impulsiveness scale and a monetary delayed behavioral task using a computer. The results showed a higher impulsivity in cocaine dependent volunteers compared to control individuals and this outcome was not related to a history of aggressive behavior (<xref ref-type="bibr" rid="B88">Moeller et al., 2002</xref>). Importantly, the impulsiveness scale applied did not distinguish between social and non-social related impulsive behavior. In another study, detoxified cocaine-dependent patients had higher levels of physical aggression and hostility, and also, higher levels of dysfunctional impulsivity than healthy control subjects (<xref ref-type="bibr" rid="B109">Roozen et al., 2011</xref>). On the other hand, in the context of ADHD treatment, it has been shown that the treatment with MPH was effective on aggressive behavior when ADHD is comorbid with oppositional defiant disorder and aggression (<xref ref-type="bibr" rid="B82">Masi et al., 2017</xref>). However, this study has several limitations (non-randomized, non-blinded and few patients), and therefore more studies are needed to elucidate the effect of psychostimulants on aggressive behaviors, when used as a therapeutic treatment.</p>
<p>
<xref ref-type="table" rid="T2">Table 2</xref> summarizes the results of the studies evaluating the effects of different psychostimulants upon diverse social behaviors in humans.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Human research summary in social behaviors.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Ref.</th>
<th rowspan="2" align="center">Drug</th>
<th rowspan="2" align="center">Dose</th>
<th rowspan="2" align="center">Treatment</th>
<th align="center">Main results reported</th>
<th rowspan="2" align="center">Important factors considered</th>
</tr>
<tr>
<th align="center">Social activity</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td colspan="6" align="center">Pro sociality and empathy</td>
</tr>
<tr>
<td rowspan="2" align="left">
<xref ref-type="bibr" rid="B141">Wardle and de Wit (2014)</xref>
</td>
<td rowspan="3" align="center">MDMA</td>
<td rowspan="2" align="center">0.75 and 1.5&#xa0;mg/kg</td>
<td rowspan="2" align="center">Three-sessions treatment; each session separated by a minimum of 7 days</td>
<td align="left">Increased smiling and reduced frown, altering emotional processing and response. Increased use of positive emotion words</td>
<td rowspan="2" align="left">36 healthy volunteers, ages 18&#x2013;35, with previous ecstasy use. Drug administrated in isolated laboratory setups</td>
</tr>
<tr>
<td align="left">1.5&#xa0;mg/kg increased ratings of perceived regard during the social interaction and increased ratings of empathy</td>
</tr>
<tr>
<td align="left">
<xref ref-type="bibr" rid="B20">Bedi et al. (2010),</xref> <xref ref-type="bibr" rid="B62">Kirkpatrick and de Wit (2015)</xref>
</td>
<td align="left">1.5 and 1&#xa0;mg/kg</td>
<td align="left">Acute treatment. Measures evaluated 2&#x2013;4&#xa0;min after drug administration</td>
<td align="left">Increased feelings of confidence when others accompanied subjects. Also increased ratings of attractiveness of the other person and increased social interaction</td>
<td align="left">Healthy Young adult volunteers aged 18&#x2013;35 with moderate MDMA experience (4&#x2013;80 lifetime uses)</td>
</tr>
<tr>
<td align="left">
<xref ref-type="bibr" rid="B106">Quednow, 2017</xref>; <xref ref-type="bibr" rid="B73">Li et al. (2022)</xref>
</td>
<td align="center">MAMPH</td>
<td colspan="2" align="center">Chronic use</td>
<td align="left">Lower emotional empathy, smaller social networks and increased non pro social choices</td>
<td align="left">Non-medical use in males and females with drug use disorder</td>
</tr>
<tr>
<td colspan="6" align="center">Parenting behavior</td>
</tr>
<tr>
<td align="left">
<xref ref-type="bibr" rid="B142">Waxmonsky et al. (2014)</xref>
</td>
<td align="center">LDX</td>
<td align="left">30, 50 or 70&#xa0;mg/day</td>
<td align="left">3-week open label titration to determine optimal dose for each. Evaluation begun the week after dose optimization</td>
<td align="left">Improved parenting behaviors, reduced negative talk during the free play and quiet time components. Also, increased praising statements, reduced verbalizations during homework task and the percentage of demands during tasks</td>
<td align="left">Parents with ADHD diagnostic (27% male)</td>
</tr>
<tr>
<td colspan="6" align="center">Aggressive behavior</td>
</tr>
<tr>
<td align="left">
<xref ref-type="bibr" rid="B113">Sekine et al. (2006),</xref> <xref ref-type="bibr" rid="B103">Pl&#xfc;ddemann et al. (2010),</xref> <xref ref-type="bibr" rid="B98">Payer et al. (2012),</xref> <xref ref-type="bibr" rid="B68">Lederer et al. (2016)</xref>
</td>
<td align="center">MAMPH</td>
<td colspan="2" align="center">Chronic use</td>
<td align="left">Increased aggressive behaviors, violence, or trait aggression. Higher levels of physical aggression and anger</td>
<td align="left">1561 humans (53% females) between 12&#x2013;17 years with MAMPH use disorder</td>
</tr>
<tr>
<td align="left">
<xref ref-type="bibr" rid="B82">Masi et al. (2017)</xref>
</td>
<td align="center">MPH</td>
<td align="left">5&#x2013;10&#xa0;mg/day</td>
<td align="left">Monotherapy during the follow up. Titrations of 5&#x2013;10&#xa0;mg no more frequently than a 5 days intervals</td>
<td align="left">Reduced aggressive behavior</td>
<td align="left">20 males between 6 and 12 years with diagnosed ADHD and oppositional defiant disorder and aggression; without previous pharmacotherapy</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s5">
<title>5 Concluding remarks and future considerations</title>
<p>There is mounting evidence, both from animal models and human studies, showing that psychostimulants can significantly affect social behaviors. This is not surprising considering that the neural circuits underlying the regulation and expression of social behaviors are highly overlapped with those targeted by psychostimulants, which in most cases have strong rewarding and consequently addictive properties. Thus, it is also not surprising that the effects of psychostimulants on these behaviors can be very different depending on numerous variables such as the type of drug considered, acute <italic>versus</italic> long-term use, clinical <italic>versus</italic> recreational consumption or the presence or absence of concomitant risk factors (e.g., neuropsychiatric comorbidities, simultaneous consumption of other drugs, etc.), to name a few.</p>
<p>Furthermore, even though we used that terminology in this work, we think that considering psychostimulants as a relatively homogeneous drug class might be a misleading approach. Thus, the diverse effects on monoamines, i.e., more pronounced effects on DA and/or NE and/or 5-HT, as well as their differential pharmacodynamics regarding monoamines uptake (blockers, releasers, partial releasers, etc.) should be considered carefully when assessing the impact of different psychostimulants upon social behaviors.</p>
<p>In our opinion, psychostimulants-induced changes in social behaviors, either prosocial or antisocial, should be always monitored, particularly when using this type of drugs in therapeutic contexts. This assessment will be not only beneficial to establish some specific behavioral effects and how these can translate to neurochemistry, but also would shed light on how this dimension can be used/modified to improve the desired clinical outcomes and to reduce the risk of abuse and/or addiction. Indeed, studies in rodents have shown that the interaction with a partner during the acquisition of addictive behavior or relapse decreases the chances of developing addiction (noteworthy, opposite results were found if the partner also uses the drug) (<xref ref-type="bibr" rid="B112">Sampedro-Piquero et al., 2019</xref>; <xref ref-type="bibr" rid="B134">Venniro et al., 2022</xref>). Therefore, it is essential to consider the reward elicited by social interaction as an important factor that could improve addiction treatments.</p>
<p>Despite these considerations, it is clear that much more research is needed to have a better understanding of the physiological mechanisms underlying different social behaviors and how they are affected by diverse psychostimulants. This seems to be of particular relevance in a scenario of a growing consumption of this type of compounds.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Author contributions</title>
<p>VC-J: Writing&#x2013;original draft, Writing&#x2013;review and editing. TB: Writing&#x2013;review and editing. AC: Writing&#x2013;original draft. IA: Writing&#x2013;original draft. MR-P: Writing&#x2013;original draft, Writing&#x2013;review and editing. GR: Writing&#x2013;original draft, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s7">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Proyecto POSTDOC_DICYT 022101RP, Vicerrector&#xed;a de Investigaci&#xf3;n, Desarrollo e Innovaci&#xf3;n, DICYT, Universidad de Santiago de Chile. FONDECYT Grants 1220656 and 1230446 (MR-P).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Achterberg</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Trezza</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Siviy</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Schrama</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Schoffelmeer</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Vanderschuren</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Amphetamine and cocaine suppress social play behavior in rats through distinct mechanisms</article-title>. <source>Psychopharmacology</source> <volume>231</volume>, <fpage>1503</fpage>&#x2013;<lpage>1515</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-013-3272-9</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Achterberg</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Van Kerkhof</surname>
<given-names>L. W.</given-names>
</name>
<name>
<surname>Servadio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Van Swieten</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Houwing</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Aalderink</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Contrasting roles of dopamine and noradrenaline in the motivational properties of social play behavior in rats</article-title>. <source>Neuropsychopharmacology</source> <volume>41</volume>, <fpage>858</fpage>&#x2013;<lpage>868</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2015.212</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Achterberg</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>van Kerkhof</surname>
<given-names>L. W.</given-names>
</name>
<name>
<surname>Damsteegt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Trezza</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Vanderschuren</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Methylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats</article-title>. <source>J. Neurosci.</source> <volume>35</volume>, <fpage>161</fpage>&#x2013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2945-14.2015</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahloy-Dallaire</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Espinosa</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Play and optimal welfare: does play indicate the presence of positive affective states?</article-title> <source>Behav. Process.</source> <volume>156</volume>, <fpage>3</fpage>&#x2013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.beproc.2017.11.011</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahrens</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>Aldridge</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Dynamic encoding of incentive salience in the ventral pallidum: dependence on the form of the reward cue</article-title>. <source>eneuro</source> <volume>5</volume>, <fpage>ENEURO.0328</fpage>. <pub-id pub-id-type="doi">10.1523/ENEURO.0328-17.2018</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alkalay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dan</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Effect of short-term methylphenidate on social impairment in children with attention deficit/hyperactivity disorder: systematic review</article-title>. <source>Child. Adolesc. Psychiatry Ment. Health</source> <volume>16</volume>, <fpage>93</fpage>. <pub-id pub-id-type="doi">10.1186/s13034-022-00526-2</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alves</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Magalh&#xe3;es</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Melo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>de Sousa</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tavares</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Monteiro</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Long-term effects of chronic cocaine exposure throughout adolescence on anxiety and stress responsivity in a Wistar rat model</article-title>. <source>Neuroscience</source> <volume>277</volume>, <fpage>343</fpage>&#x2013;<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.07.008</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ambroggi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ghazizadeh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nicola</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Fields</surname>
<given-names>H. L.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Roles of nucleus accumbens core and shell in incentive-cue responding and behavioral inhibition</article-title>. <source>J. Neurosci.</source> <volume>31</volume>, <fpage>6820</fpage>&#x2013;<lpage>6830</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6491-10.2011</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amiri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mohammadi</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Mohammadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nouroozinejad</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Kahbazi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akhondzadeh</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial</article-title>. <source>Prog. Neuropsychopharmacol. Biol. Psychiatry</source> <volume>32</volume>, <fpage>145</fpage>&#x2013;<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2007.07.025</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anastasiades</surname>
<given-names>P. G.</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Circuit organization of the rodent medial prefrontal cortex</article-title>. <source>Trends Neurosci.</source> <volume>44</volume> (<issue>7</issue>), <fpage>550</fpage>&#x2013;<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2021.03.006</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement</article-title>. <source>Pharmacol. Ther.</source> <volume>106</volume>, <fpage>389</fpage>&#x2013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2004.12.004</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Argue</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2015a</year>). <article-title>Utilization of same-vs. mixed-sex dyads impacts the observation of sex differences in juvenile social play behavior</article-title>. <source>Curr. Neurobiol.</source> <volume>6</volume>, <fpage>17</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.4172/0975-9042.000117</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Argue</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2015b</year>). <article-title>Characterization of juvenile play in rats: importance of sex of self and sex of partner</article-title>. <source>Biol. Sex. Differ.</source> <volume>6</volume>, <fpage>16</fpage>. <pub-id pub-id-type="doi">10.1186/s13293-015-0034-x</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Feifel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Earl</surname>
<given-names>C. Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Adler</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD</article-title>. <source>J. Atten. Disord.</source> <volume>18</volume>, <fpage>133</fpage>&#x2013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1177/1087054712441969</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aron</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Paulus</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use</article-title>. <source>Addiction</source> <volume>102</volume> (<issue>Suppl. 1</issue>), <fpage>33</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1111/j.1360-0443.2006.01778.x</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arria</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>DuPont</surname>
<given-names>R. L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Nonmedical prescription stimulant use among college students: why we need to do something and what we need to do</article-title>. <source>J. Addict. Dis.</source> <volume>29</volume>, <fpage>417</fpage>&#x2013;<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1080/10550887.2010.509273</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baggott</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Kirkpatrick</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Bedi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>de Wit</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Intimate insight: MDMA changes how people talk about significant others</article-title>. <source>J. Psychopharmacol.</source> <volume>29</volume> (<issue>6</issue>), <fpage>669</fpage>&#x2013;<lpage>677</lpage>. <pub-id pub-id-type="doi">10.1177/0269881115581962</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bardo</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Neisewander</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Individual differences and social influences on the neurobehavioral pharmacology of abused drugs</article-title>. <source>Pharmacol. Rev.</source> <volume>65</volume>, <fpage>255</fpage>&#x2013;<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1124/pr.111.005124</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartholow</surname>
<given-names>B. D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The aggressive brain: insights from neuroscience</article-title>. <source>Curr. Opin. Psychol.</source> <volume>19</volume>, <fpage>60</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.copsyc.2017.04.002</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>de Wit</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Is ecstasy an "empathogen"? Effects of &#xb1;3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others</article-title>. <source>Biol. Psychiatry</source> <volume>68</volume> (<issue>12</issue>), <fpage>1134</fpage>&#x2013;<lpage>1140</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.08.003</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berridge</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Kringelbach</surname>
<given-names>M. L.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Pleasure systems in the brain</article-title>. <source>Neuron</source> <volume>86</volume>, <fpage>646</fpage>&#x2013;<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.02.018</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berridge</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>T. E.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Liking, wanting, and the incentive-sensitization theory of addiction</article-title>. <source>Am. Psychol.</source> <volume>71</volume>, <fpage>670</fpage>&#x2013;<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1037/amp0000059</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolanos</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Barrot</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Berton</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Wallace-Black</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nestler</surname>
<given-names>E. J.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood</article-title>. <source>Biol. Psychiatry</source> <volume>54</volume>, <fpage>1317</fpage>&#x2013;<lpage>1329</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-3223(03)00570-5</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breckenridge</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Breckenridge</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Peck</surname>
<given-names>C. C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulation</article-title>. <source>Br. J. Clin. Pharmacol.</source> <volume>85</volume>, <fpage>1874</fpage>&#x2013;<lpage>1877</lpage>. <pub-id pub-id-type="doi">10.1111/bcp.14026</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bucher</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Vu</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Hojat</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Psychostimulant drug abuse and personality factors in medical students</article-title>. <source>Med. Teach.</source> <volume>35</volume> (<issue>1</issue>), <fpage>53</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.3109/0142159X.2012.731099</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caldwell</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Kunkle</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>H. G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Differential effects of modafinil on performance of low-performing and high-performing individuals during total sleep deprivation</article-title>. <source>Pharmacol. Biochem. Behav.</source> <volume>196</volume>, <fpage>172968</fpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2020.172968</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Neural circuit mechanisms of social behavior</article-title>. <source>Neuron</source> <volume>98</volume>, <fpage>16</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.02.026</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cid-Jofre</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Garate-Perez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Valero-Jara</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Espana</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Sotomayor-Zarate</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Chronic modafinil administration to preadolescent rats impairs social play behavior and dopaminergic system</article-title>. <source>Neuropharmacology</source> <volume>183</volume>, <fpage>108404</fpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2020.108404</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clare</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Volkow</surname>
<given-names>N. D.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Cocaine reduces the neuronal population while upregulating dopamine D2-receptor-expressing neurons in brain reward regions: sex-effects</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>, <fpage>624127</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.624127</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>d&#x2019;Angelo</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Savulich</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sahakian</surname>
<given-names>B. J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure</article-title>. <source>Br. J. Pharmacol.</source> <volume>174</volume>, <fpage>3257</fpage>&#x2013;<lpage>3267</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13813</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dawe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lapworth</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>McKetin</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Mechanisms underlying aggressive and hostile behavior in amphetamine users</article-title>. <source>Curr. Opin. Psychiatry</source> <volume>22</volume>, <fpage>269</fpage>&#x2013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1097/YCO.0b013e32832a1dd4</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>de Wit</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>J. B.</given-names>
</name>
</person-group> (<year>2004</year>). &#x201c;<article-title>Dual determinants of drug use in humans: reward and impulsivity</article-title>,&#x201d; in <source>Motivational factors in the etiology of drug abuse volume 50 of the Nebraska symposium on motivation</source>. Editors <person-group person-group-type="editor">
<name>
<surname>Bevins</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Michael</surname>
<given-names>T. B.</given-names>
</name>
</person-group> (<publisher-loc>Lincoln, NE</publisher-loc>: <publisher-name>University of Nebraska Press</publisher-name>), <fpage>19</fpage>&#x2013;<lpage>55</lpage>.</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Douglas</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Halverstadt</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Reinhart-Anez</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Webber</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cromwell</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>A possible social relative reward effect: influences of outcome inequity between rats during operant responding</article-title>. <source>Behav. Process.</source> <volume>157</volume>, <fpage>459</fpage>&#x2013;<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1016/j.beproc.2018.06.016</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Douglas</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Varlinskaya</surname>
<given-names>E. I.</given-names>
</name>
<name>
<surname>Spear</surname>
<given-names>L. P.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Rewarding properties of social interactions in adolescent and adult male and female rats: impact of social versus isolate housing of subjects and partners</article-title>. <source>Dev. Psychobiol.</source> <volume>45</volume>, <fpage>153</fpage>&#x2013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1002/dev.20025</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunlap</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>D. E.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Dark classics in chemical neuroscience: 3,4-methylenedioxymethamphetamine</article-title>. <source>ACS Chem. Neurosci.</source> <volume>9</volume> (<issue>10</issue>), <fpage>2408</fpage>&#x2013;<lpage>2427</lpage>. <pub-id pub-id-type="doi">10.1021/acschemneuro.8b00155</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>EllenLeslie</surname>
<given-names>M. E. M.</given-names>
</name>
<name>
<surname>Andrew Smirnov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Adrian Cherney</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Helene Wells</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Margot Legosz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Robert Kemp</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Simultaneous use of alcohol with methamphetamine but not ecstasy linked with aggression among young adult stimulant users</article-title>. <source>Addict. Behav.</source> <volume>70</volume>, <fpage>27</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.addbeh.2017.01.036</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Estelles</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rodriguez-Arias</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aguilar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Minarro</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Social behavioural profile of cocaine in isolated and grouped male mice</article-title>. <source>Drug alcohol dependence</source> <volume>76</volume>, <fpage>115</fpage>&#x2013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2004.04.019</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fantozzi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Muratori</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Caponi</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Levantini</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Nardoni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pfanner</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Treatment with methylphenidate improves affective but not cognitive empathy in youths with attention-deficit/hyperactivity disorder</article-title>. <source>Child. (Basel)</source> <volume>8</volume> (<issue>7</issue>), <fpage>596</fpage>. <pub-id pub-id-type="doi">10.3390/children8070596</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fantozzi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sesso</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Muratori</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Milone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Masi</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2021a</year>). <article-title>Biological bases of empathy and social cognition in patients with attention-deficit/hyperactivity disorder: a focus on treatment with psychostimulants</article-title>. <source>Brain Sci.</source> <volume>11</volume> (<issue>11</issue>), <fpage>1399</fpage>. <pub-id pub-id-type="doi">10.3390/brainsci11111399</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faraone</surname>
<given-names>S. V.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>87</volume>, <fpage>255</fpage>&#x2013;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2018.02.001</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feduccia</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Jerome</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yazar-Klosinski</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Emerson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mithoefer</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Doblin</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Breakthrough for trauma treatment: safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline</article-title>. <source>Focus Am Psychiatr. Publ.</source> <volume>21</volume> (<issue>3</issue>), <fpage>306</fpage>&#x2013;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1176/appi.focus.23021013</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>O&#x2019;Connell</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Circuit architecture underlying distinct components of parental care</article-title>. <source>Trends Neurosci.</source> <volume>41</volume>, <fpage>334</fpage>&#x2013;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2018.04.003</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fox</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Bergquist</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Casey</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Selective cocaine-related difficulties in emotional intelligence: relationship to stress and impulse control</article-title>. <source>Am. J. Addict.</source> <volume>20</volume> (<issue>2</issue>), <fpage>151</fpage>&#x2013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1111/j.1521-0391.2010.00108.x</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franklin</surname>
<given-names>T. B.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Perova</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Marrone</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Masferrer</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Prefrontal cortical control of a brainstem social behavior circuit</article-title>. <source>Nat. Neurosci.</source> <volume>20</volume>, <fpage>260</fpage>&#x2013;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4470</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goez</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Nevo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bennett-Back</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Zelnik</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial</article-title>. <source>J. Child Neurology</source> <volume>27</volume>, <fpage>1547</fpage>&#x2013;<lpage>1552</lpage>. <pub-id pub-id-type="doi">10.1177/0883073812439101</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golden</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shaham</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Animal models of (or for) aggression reward, addiction, and relapse: behavior and circuits</article-title>. <source>J. Neurosci.</source> <volume>39</volume>, <fpage>3996</fpage>&#x2013;<lpage>4008</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0151-19.2019</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodwin</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Swant</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Javitch</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Zahniser</surname>
<given-names>N. R.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Amphetamine and methamphetamine differentially affect dopamine transporters <italic>in vitro</italic> and <italic>in vivo</italic>
</article-title>. <source>J. Biol. Chem.</source> <volume>284</volume>, <fpage>2978</fpage>&#x2013;<lpage>2989</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M805298200</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groppe</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Gossen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rademacher</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Westphal</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Grunder</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain</article-title>. <source>Biol. Psychiatry</source> <volume>74</volume>, <fpage>172</fpage>&#x2013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2012.12.023</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunaydin</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Grosenick</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Kauvar</surname>
<given-names>I. V.</given-names>
</name>
<name>
<surname>Fenno</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Adhikari</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Natural neural projection dynamics underlying social behavior</article-title>. <source>Cell</source> <volume>157</volume>, <fpage>1535</fpage>&#x2013;<lpage>1551</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.05.017</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heilig</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Nader</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Shaham</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Time to connect: bringing social context into addiction neuroscience</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>17</volume>, <fpage>592</fpage>&#x2013;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1038/nrn.2016.67</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henry</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Mazur</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rendell</surname>
<given-names>P. G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Social-cognitive difficulties in former users of methamphetamine</article-title>. <source>Br. J. Clin. Psychol.</source> <volume>48</volume> (<issue>Pt 3</issue>), <fpage>323</fpage>&#x2013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1348/000712609X435742</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Homberg</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Schiepers</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>Schoffelmeer</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Cuppen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vanderschuren</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent rats</article-title>. <source>Psychopharmacology</source> <volume>195</volume>, <fpage>175</fpage>&#x2013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-007-0895-8</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoover</surname>
<given-names>W. B.</given-names>
</name>
<name>
<surname>Vertes</surname>
<given-names>R. P.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat</article-title>. <source>Brain Struct. Funct.</source> <volume>212</volume> (<issue>2</issue>), <fpage>149</fpage>&#x2013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1007/s00429-007-0150-4</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hostetler</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Ryabinin</surname>
<given-names>A. E.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Methamphetamine consumption inhibits pair bonding and hypothalamic oxytocin in prairie voles</article-title>. <source>PLoS One</source> <volume>11</volume>, <fpage>e0158178</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0158178</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hung</surname>
<given-names>L. W.</given-names>
</name>
<name>
<surname>Neuner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Polepalli</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Beier</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>J. J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Gating of social reward by oxytocin in the ventral tegmental area</article-title>. <source>Science</source> <volume>357</volume>, <fpage>1406</fpage>&#x2013;<lpage>1411</lpage>. <pub-id pub-id-type="doi">10.1126/science.aan4994</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyman</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Malenka</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Nestler</surname>
<given-names>E. J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Neural mechanisms of addiction: the role of reward-related learning and memory</article-title>. <source>Annu. Rev. Neurosci.</source> <volume>29</volume>, <fpage>565</fpage>&#x2013;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.29.051605.113009</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jager</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kanters</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Geers</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Kozicz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Glennon</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Methylphenidate dose-dependently affects aggression and improves fear extinction and anxiety in BALB/cJ mice</article-title>. <source>Front. Psychiatry</source> <volume>10</volume>, <fpage>768</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyt.2019.00768</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johns</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>McMurray</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Hofler</surname>
<given-names>V. E.</given-names>
</name>
<name>
<surname>Jarrett</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Middleton</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>D. L.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Cocaine disrupts pup-induced maternal behavior in juvenile and adult rats</article-title>. <source>Neurotoxicol Teratol.</source> <volume>29</volume>, <fpage>634</fpage>&#x2013;<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2007.07.003</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kangaslampi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zijlmans</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations</article-title>. <source>Eur. Child. Adolesc. Psychiatry</source>. <pub-id pub-id-type="doi">10.1007/s00787-023-02310-9</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karen Pierce</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Frank Haist</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Farshad Sedaghat</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Eric Courchesne</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>The brain response to personally familiar faces in autism: findings of fusiform activity and beyond</article-title>. <source>Brain</source> <volume>127</volume> (<issue>12</issue>), <fpage>2703</fpage>&#x2013;<lpage>2716</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awh289</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y. T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M. N.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Alterations in cortical activity of male methamphetamine abusers performing an empathy task: fMRI study</article-title>. <source>Hum. Psychopharmacol.</source> <volume>25</volume> (<issue>1</issue>), <fpage>63</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1002/hup.1083</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirkpatrick</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>de Wit</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>MDMA: a social drug in a social context</article-title>. <source>Psychopharmacol. Berl.</source> <volume>232</volume> (<issue>6</issue>), <fpage>1155</fpage>&#x2013;<lpage>1163</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-014-3752-6</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Knell</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2022</year>). &#x201c;<article-title>Cognitive behavioral play therapy</article-title>,&#x201d; in <source>Creative CBT with youth</source> (<publisher-name>Springer</publisher-name>), <fpage>65</fpage>&#x2013;<lpage>82</lpage>.</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koob</surname>
<given-names>G. F.</given-names>
</name>
<name>
<surname>Volkow</surname>
<given-names>N. D.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Neurocircuitry of addiction</article-title>. <source>Neuropsychopharmacology</source> <volume>35</volume>, <fpage>217</fpage>&#x2013;<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2009.110</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koob</surname>
<given-names>G. F.</given-names>
</name>
<name>
<surname>Volkow</surname>
<given-names>N. D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Neurobiology of addiction: a neurocircuitry analysis</article-title>. <source>Lancet Psychiatry</source> <volume>3</volume>, <fpage>760</fpage>&#x2013;<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1016/S2215-0366(16)00104-8</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koolhaas</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Coppens</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>de Boer</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Buwalda</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Meerlo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Timmermans</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The resident-intruder paradigm: a standardized test for aggression, violence and social stress</article-title>. <source>JoVE J. Vis. Exp.</source>, <fpage>e4367</fpage>. <pub-id pub-id-type="doi">10.3791/4367</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lakhan</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Kirchgessner</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects</article-title>. <source>Brain Behav.</source> <volume>2</volume>, <fpage>661</fpage>&#x2013;<lpage>677</lpage>. <pub-id pub-id-type="doi">10.1002/brb3.78</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lederer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fouche</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Uhlmann</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Frontal white matter changes and aggression in methamphetamine dependence</article-title>. <source>Metab. Brain Dis.</source> <volume>31</volume>, <fpage>53</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-015-9775-9</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Lonstein</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Effects of pair bonding on parental behavior and dopamine activity in the nucleus accumbens in male prairie voles</article-title>. <source>Eur. J. Neurosci.</source> <volume>46</volume>, <fpage>2276</fpage>&#x2013;<lpage>2284</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.13673</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lesscher</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Spoelder</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rotte</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Hesseling</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lozeman-van&#x2019;t Klooster</surname>
<given-names>J. G.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Early social isolation augments alcohol consumption in rats</article-title>. <source>Behav. Pharmacol.</source> <volume>26</volume>, <fpage>673</fpage>&#x2013;<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1097/FBP.0000000000000165</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levi-Shachar</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Gvirts</surname>
<given-names>H. Z.</given-names>
</name>
<name>
<surname>Goldwin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bloch</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shamay-Tsoory</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The association between symptom severity and theory of mind impairment in children with attention deficit/hyperactivity disorder</article-title>. <source>Psychiatry Res.</source> <volume>303</volume>, <fpage>114092</fpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2021.114092</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levy</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Tamir</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Parabucki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weissbrod</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schneidman</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Dynamics of social representation in the mouse prefrontal cortex</article-title>. <source>Nat. Neurosci.</source> <volume>22</volume>, <fpage>2013</fpage>&#x2013;<lpage>2022</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-019-0531-z</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>T. F.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>L. L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Impaired social decision-making in males with methamphetamine use disorder</article-title>. <source>Addict. Biol.</source> <volume>27</volume>, <fpage>e13204</fpage>. <pub-id pub-id-type="doi">10.1111/adb.13204</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lippard</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Jarrett</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>McMurray</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Zeskind</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Garber</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Zoghby</surname>
<given-names>C. R.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Early postpartum pup preference is altered by gestational cocaine treatment: associations with infant cues and oxytocin expression in the MPOA</article-title>. <source>Behav. Brain Res.</source> <volume>278</volume>, <fpage>176</fpage>&#x2013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2014.09.045</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aragona</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Kabbaj</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mazei-Robison</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Nucleus accumbens dopamine mediates amphetamine-induced impairment of social bonding in a monogamous rodent species</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>107</volume>, <fpage>1217</fpage>&#x2013;<lpage>1222</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0911998107</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Aragona</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Social bonding decreases the rewarding properties of amphetamine through a dopamine D1 receptor-mediated mechanism</article-title>. <source>J. Neurosci.</source> <volume>31</volume>, <fpage>7960</fpage>&#x2013;<lpage>7966</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1006-11.2011</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lukkes</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Watt</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Lowry</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Forster</surname>
<given-names>G. L.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Consequences of post-weaning social isolation on anxiety behavior and related neural circuits in rodents</article-title>. <source>Front. Behav. Neurosci.</source> <volume>3</volume>, <fpage>18</fpage>. <pub-id pub-id-type="doi">10.3389/neuro.08.018.2009</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machalova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Slais</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vrskova</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sulcova</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Differential effects of modafinil, methamphetamine, and MDMA on agonistic behavior in male mice</article-title>. <source>Pharmacol. Biochem. Behav.</source> <volume>102</volume>, <fpage>215</fpage>&#x2013;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2012.04.013</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mackey</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Paulus</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?</article-title> <source>Neurosci. Biobehav Rev.</source> <volume>37</volume> (<issue>3</issue>), <fpage>300</fpage>&#x2013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.12.003</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malinov&#xe1;-&#x160;ev&#x10d;&#xed;kov&#xe1;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hreb&#xed;&#x10d;kov&#xe1;</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mac&#xfa;chov&#xe1;</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nov&#xe1;</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pometlov&#xe1;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>&#x160;lamberov&#xe1;</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Differences in maternal behavior and development of their pups depend on the time of methamphetamine exposure during gestation period</article-title>. <source>Physiological Res.</source> <volume>63</volume>, <fpage>S559</fpage>&#x2013;<lpage>S572</lpage>. <pub-id pub-id-type="doi">10.33549/physiolres.932925</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manduca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Servadio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Damsteegt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Campolongo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vanderschuren</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Trezza</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Dopaminergic neurotransmission in the nucleus accumbens modulates social play behavior in rats</article-title>. <source>Neuropsychopharmacology</source> <volume>41</volume>, <fpage>2215</fpage>&#x2013;<lpage>2223</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2016.22</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Manfredi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nieri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Muratori</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pfanner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Milone</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A naturalistic comparison of methylphenidate and risperidone monotherapy in drug-naive youth with attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder and aggression</article-title>. <source>J. Clin. Psychopharmacol.</source> <volume>37</volume> (<issue>5</issue>), <fpage>590</fpage>&#x2013;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1097/JCP.0000000000000747</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCreary</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Filip</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Psychostimulants: basic and clinical pharmacology</article-title>. <source>Neuropsychiatric Complicat. Stimul. Abuse</source> <volume>120</volume>, <fpage>41</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/bs.irn.2015.02.008</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGraw</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The prairie vole: an emerging model organism for understanding the social brain</article-title>. <source>Trends Neurosci.</source> <volume>33</volume>, <fpage>103</fpage>&#x2013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2009.11.006</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miczek</surname>
<given-names>K. A.</given-names>
</name>
</person-group> (<year>1974</year>). <article-title>Intraspecies aggression in rats: effects of d-amphetamine and chlordiazepoxide</article-title>. <source>Psychopharmacologia</source> <volume>39</volume>, <fpage>275</fpage>&#x2013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1007/BF00422968</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miczek</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Tidey</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Amphetamines: aggressive and social behavior</article-title>. <source>NIDA Res. Monogr.</source> <volume>94</volume>, <fpage>68</fpage>&#x2013;<lpage>100</lpage>.</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>J. D.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>An integrative theory of prefrontal cortex function</article-title>. <source>Annu. Rev. Neurosci.</source> <volume>24</volume>, <fpage>167</fpage>&#x2013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.24.1.167</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moeller</surname>
<given-names>F. G.</given-names>
</name>
<name>
<surname>Dougherty</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Barratt</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Oderinde</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mathias</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Harper</surname>
<given-names>R. A.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression</article-title>. <source>Drug Alcohol Depend.</source> <volume>68</volume>, <fpage>105</fpage>&#x2013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/s0376-8716(02)00106-0</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monterosso</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Ainslie</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cordova</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Domier</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>London</surname>
<given-names>E. D.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task</article-title>. <source>Hum. Brain Mapp.</source> <volume>28</volume> (<issue>5</issue>), <fpage>383</fpage>&#x2013;<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.20281</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Deficient fear recognition in regular cocaine users is not attributable to elevated impulsivity or conduct disorder prior to cocaine use</article-title>. <source>J. Psychopharmacol.</source> <volume>27</volume> (<issue>6</issue>), <fpage>526</fpage>&#x2013;<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1177/0269881113477708</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nephew</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Febo</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Effect of cocaine sensitization prior to pregnancy on maternal care and aggression in the rat</article-title>. <source>Psychopharmacol. Berl.</source> <volume>209</volume>, <fpage>127</fpage>&#x2013;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-010-1777-z</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nichols</surname>
<given-names>D. E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Entactogens: how the name for a novel class of psychoactive agents originated</article-title>. <source>Front. Psychiatry</source> <volume>13</volume>, <fpage>863088</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyt.2022.863088</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="book">
<collab>NIDA</collab> (<year>2023</year>). <source>Methamphetamine overview - research reports</source>.</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Connell</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Genes, hormones, and circuits: an integrative approach to study the evolution of social behavior</article-title>. <source>Front. Neuroendocrinol.</source> <volume>32</volume>, <fpage>320</fpage>&#x2013;<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1016/j.yfrne.2010.12.004</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Olivier</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2002</year>). &#x201c;<article-title>Animal models of aggression</article-title>,&#x201d; in <source>Neuropsychopharmacology: the fifth generation of progress</source> <volume>Vol. 118</volume>, <fpage>1699</fpage>&#x2013;<lpage>1708</lpage>.</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Malley</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Casey</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Downey</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Methamphetamine, amphetamine, and aggression in humans: a systematic review of drug administration studies</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>141</volume>, <fpage>104805</fpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2022.104805</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ottenheimer</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Janak</surname>
<given-names>P. H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Reward activity in ventral pallidum tracks satiety-sensitive preference and drives choice behavior</article-title>. <source>Sci. Adv.</source> <volume>6</volume>, <fpage>eabc9321</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.abc9321</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Payer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nurmi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McCracken</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>London</surname>
<given-names>E. D.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry</article-title>. <source>Transl. Psychiatry</source> <volume>2</volume>, <fpage>e80</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2011.73</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pellis</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Pellis</surname>
<given-names>V. C.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Play&#x2010;fighting differs from serious fighting in both target of attack and tactics of fighting in the laboratory rat <italic>Rattus norvegicus</italic>
</article-title>. <source>Aggress. Behav.</source> <volume>13</volume>, <fpage>227</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1002/1098-2337(1987)13:4&#x3c;227::aid-ab2480130406&#x3e;3.0.co;2-c</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pellis</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Pellis</surname>
<given-names>V. C.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Differential rates of attack, defense, and counterattack during the developmental decrease in play fighting by male and female rats</article-title>. <source>Dev. Psychobiol.</source> <volume>23</volume>, <fpage>215</fpage>&#x2013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1002/dev.420230303</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perry</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Ortiz</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Cushing</surname>
<given-names>B. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Effects of methamphetamine on alloparental behavior in male and female prairie voles</article-title>. <source>Physiol. Behav.</source> <volume>203</volume>, <fpage>128</fpage>&#x2013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2017.09.012</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piantadosi</surname>
<given-names>P. T.</given-names>
</name>
<name>
<surname>Yeates</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Floresco</surname>
<given-names>S. B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Cooperative and dissociable involvement of the nucleus accumbens core and shell in the promotion and inhibition of actions during active and inhibitory avoidance</article-title>. <source>Neuropharmacology</source> <volume>138</volume>, <fpage>57</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2018.05.028</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pl&#xfc;ddemann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Flisher</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>McKetin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Parry</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lombard</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Methamphetamine use, aggressive behavior and other mental health issues among high-school students in Cape Town, South Africa</article-title>. <source>Drug Alcohol Depend.</source> <volume>109</volume> (<issue>1-3</issue>), <fpage>14</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2009.11.021</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponchio</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Teodorov</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kirsten</surname>
<given-names>T. B.</given-names>
</name>
<name>
<surname>Coelho</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Oshiro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Florio</surname>
<given-names>J. C.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Repeated methylphenidate administration during lactation reduces maternal behavior, induces maternal tolerance, and increases anxiety-like behavior in pups in adulthood</article-title>. <source>Neurotoxicology Teratol.</source> <volume>50</volume>, <fpage>64</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2015.05.008</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Preller</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Hulka</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Vonmoos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jenni</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Baumgartner</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Seifritz</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Impaired emotional empathy and related social network deficits in cocaine users</article-title>. <source>Addict. Biol.</source> <volume>19</volume> (<issue>3</issue>), <fpage>452</fpage>&#x2013;<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1111/adb.12070</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quednow</surname>
<given-names>B. B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Social cognition and interaction in stimulant use disorders</article-title>. <source>Curr. Opin. Behav. Sci.</source> <volume>13</volume>, <fpage>55</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.cobeha.2016.10.001</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rademacher</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Schuyler</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Kruschel</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Steinpreis</surname>
<given-names>R. E.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Effects of cocaine and putative atypical antipsychotics on rat social behavior: an ethopharmacological study</article-title>. <source>Pharmacol. Biochem. Behav.</source> <volume>73</volume>, <fpage>769</fpage>&#x2013;<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1016/s0091-3057(02)00904-8</pub-id>
</citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rigney</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Petrulis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Oxytocin, vasopressin, and social behavior: from neural circuits to clinical opportunities</article-title>. <source>Endocrinology</source> <volume>163</volume> (<issue>9</issue>), <fpage>bqac111</fpage>. <pub-id pub-id-type="doi">10.1210/endocr/bqac111</pub-id>
</citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roozen</surname>
<given-names>H. G.</given-names>
</name>
<name>
<surname>van der Kroft</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>van Marle</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Franken</surname>
<given-names>I. H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The impact of craving and impulsivity on aggression in detoxified cocaine-dependent patients</article-title>. <source>J. Subst. Abuse Treat.</source> <volume>40</volume> (<issue>4</issue>), <fpage>414</fpage>&#x2013;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsat.2010.12.003</pub-id>
</citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudebeck</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Millette</surname>
<given-names>B. H. P.</given-names>
</name>
<name>
<surname>Shirley</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rushworth</surname>
<given-names>M. F. S.</given-names>
</name>
<name>
<surname>Bannerman</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Distinct contributions of frontal areas to emotion and social behaviour in the rat</article-title>. <source>Eur. J. Neurosci.</source> <volume>26</volume> (<issue>8</issue>), <fpage>2315</fpage>&#x2013;<lpage>2326</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05844.x</pub-id>
</citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rugino</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents</article-title>. <source>Neuropsychiatr. Dis. Treat.</source> <volume>3</volume> (<issue>3</issue>), <fpage>293</fpage>&#x2013;<lpage>301</lpage>.</citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sampedro-Piquero</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>&#xc1;vila-G&#xe1;miz</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Moreno Fern&#xe1;ndez</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Castilla-Ortega</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sant&#xed;n</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The presence of a social stimulus reduces cocaine-seeking in a place preference conditioning paradigm</article-title>. <source>J. Psychopharmacol.</source> <volume>33</volume> (<issue>12</issue>), <fpage>1501</fpage>&#x2013;<lpage>1511</lpage>. <pub-id pub-id-type="doi">10.1177/0269881119874414</pub-id>
</citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekine</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ouchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takei</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Futatsubashi</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Brain serotonin transporter density and aggression in abstinent methamphetamine abusers</article-title>. <source>Arch. Gen. Psychiatry</source> <volume>63</volume> (<issue>1</issue>), <fpage>90</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.63.1.90</pub-id>
</citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shreffler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>McGee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cales</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Self-compassion in individuals with substance use disorder: the association with personal growth and well-being</article-title>. <source>J. Addict. Dis.</source> <volume>40</volume> (<issue>3</issue>), <fpage>366</fpage>&#x2013;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1080/10550887.2021.2005382</pub-id>
</citation>
</ref>
<ref id="B115">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soares-Cunha</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Heinsbroek</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Ventral pallidal regulation of motivated behaviors and reinforcement</article-title>. <source>Front. Neural Circuits</source> <volume>17</volume>, <fpage>1086053</fpage>. <pub-id pub-id-type="doi">10.3389/fncir.2023.1086053</pub-id>
</citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sofuoglu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sewell</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Norepinephrine and stimulant addiction</article-title>. <source>Addict. Biol.</source> <volume>14</volume>, <fpage>119</fpage>&#x2013;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1111/j.1369-1600.2008.00138.x</pub-id>
</citation>
</ref>
<ref id="B117">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soli&#xe9;</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Contestabile</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Espinosa</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Musardo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bariselli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Superior Colliculus to VTA pathway controls orienting response and influences social interaction in mice</article-title>. <source>Nat. Commun.</source> <volume>13</volume>, <fpage>817</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-022-28512-4</pub-id>
</citation>
</ref>
<ref id="B118">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Borland</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Larkin</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>O&#x27;Malley</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Albers</surname>
<given-names>H. E.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Activation of oxytocin receptors, but not arginine-vasopressin V1a receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions</article-title>. <source>Psychoneuroendocrinology</source> <volume>74</volume>, <fpage>164</fpage>&#x2013;<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2016.09.001</pub-id>
</citation>
</ref>
<ref id="B119">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stolzenberg</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>H. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Experience-dependent mechanisms in the regulation of parental care</article-title>. <source>Front. Neuroendocrinol.</source> <volume>54</volume>, <fpage>100745</fpage>. <pub-id pub-id-type="doi">10.1016/j.yfrne.2019.04.002</pub-id>
</citation>
</ref>
<ref id="B120">
<citation citation-type="book">
<collab>Substance Abuse and Mental Health Services Administration</collab> (<year>2014</year>). <source>Results from the 2013 national survey on drug use and health: summary of national findings, NSDUH series H-48, HHS publication No. (SMA) 14-4863. Rockville, MD: substance abuse and mental health Services administration</source>.</citation>
</ref>
<ref id="B121">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>S. F.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>A genetically encoded fluorescent sensor enables rapid and specific detection of dopamine in flies, fish, and mice</article-title>. <source>Cell</source> <volume>174</volume>, <fpage>481</fpage>&#x2013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.06.042</pub-id>
</citation>
</ref>
<ref id="B122">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Next-generation GRAB sensors for monitoring dopaminergic activity <italic>in vivo</italic>
</article-title>. <source>Nat. Methods</source> <volume>17</volume>, <fpage>1156</fpage>&#x2013;<lpage>1166</lpage>. <pub-id pub-id-type="doi">10.1038/s41592-020-00981-9</pub-id>
</citation>
</ref>
<ref id="B123">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thiel</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Okun</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Neisewander</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Social reward-conditioned place preference: a model revealing an interaction between cocaine and social context rewards in rats</article-title>. <source>Drug alcohol dependence</source> <volume>96</volume>, <fpage>202</fpage>&#x2013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2008.02.013</pub-id>
</citation>
</ref>
<ref id="B124">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trezza</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Baarendse</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Vanderschuren</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The pleasures of play: pharmacological insights into social reward mechanisms</article-title>. <source>Trends Pharmacol. Sci.</source> <volume>31</volume>, <fpage>463</fpage>&#x2013;<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2010.06.008</pub-id>
</citation>
</ref>
<ref id="B125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trezza</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Baarendse</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Vanderschuren</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>On the interaction between drugs of abuse and adolescent social behavior</article-title>. <source>Psychopharmacology</source> <volume>231</volume>, <fpage>1715</fpage>&#x2013;<lpage>1729</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-014-3471-z</pub-id>
</citation>
</ref>
<ref id="B126">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uhlmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ipser</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Social cognition and aggression in methamphetamine dependence with and without a history of psychosis</article-title>. <source>Metab. Brain Dis.</source> <volume>33</volume>, <fpage>559</fpage>&#x2013;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-017-0157-3</pub-id>
</citation>
</ref>
<ref id="B127">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Underhill</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Colt</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Amara</surname>
<given-names>S. G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Amphetamine stimulates endocytosis of the norepinephrine and neuronal glutamate transporters in cultured locus coeruleus neurons</article-title>. <source>Neurochem. Res.</source> <volume>45</volume>, <fpage>1410</fpage>&#x2013;<lpage>1419</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-019-02939-6</pub-id>
</citation>
</ref>
<ref id="B128">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanderschuren</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Achterberg</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Trezza</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The neurobiology of social play and its rewarding value in rats</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>70</volume>, <fpage>86</fpage>&#x2013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.07.025</pub-id>
</citation>
</ref>
<ref id="B129">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanderschuren</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Niesink</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Van Pee</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>The neurobiology of social play behavior in rats</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>21</volume>, <fpage>309</fpage>&#x2013;<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1016/s0149-7634(96)00020-6</pub-id>
</citation>
</ref>
<ref id="B130">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanderschuren</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Trezza</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Griffioen-Roose</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schiepers</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>Van Leeuwen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>De Vries</surname>
<given-names>T. J.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Methylphenidate disrupts social play behavior in adolescent rats</article-title>. <source>Neuropsychopharmacology</source> <volume>33</volume>, <fpage>2946</fpage>&#x2013;<lpage>2956</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2008.10</pub-id>
</citation>
</ref>
<ref id="B131">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Kerkhof</surname>
<given-names>L. W. M.</given-names>
</name>
<name>
<surname>Damsteegt</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Trezza</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Voorn</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vanderschuren</surname>
<given-names>LJMJ</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Social play behavior in adolescent rats is mediated by functional activity in medial prefrontal cortex and striatum</article-title>. <source>Neuropsychopharmacology</source> <volume>38</volume>, <fpage>1899</fpage>&#x2013;<lpage>1909</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2013.83</pub-id>
</citation>
</ref>
<ref id="B132">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Kerkhof</surname>
<given-names>L. W. M.</given-names>
</name>
<name>
<surname>Trezza</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mulder</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Voorn</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vanderschuren</surname>
<given-names>LJMJ</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Cellular activation in limbic brain systems during social play behaviour in rats</article-title>. <source>Brain Struct. Funct.</source> <volume>219</volume>, <fpage>1181</fpage>&#x2013;<lpage>1211</lpage>. <pub-id pub-id-type="doi">10.1007/s00429-013-0558-y</pub-id>
</citation>
</ref>
<ref id="B133">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varlinskaya</surname>
<given-names>E. I.</given-names>
</name>
<name>
<surname>Spear</surname>
<given-names>L. P.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Social interactions in adolescent and adult Sprague-Dawley rats: impact of social deprivation and test context familiarity</article-title>. <source>Behav. Brain Res.</source> <volume>188</volume>, <fpage>398</fpage>&#x2013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2007.11.024</pub-id>
</citation>
</ref>
<ref id="B134">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venniro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marino</surname>
<given-names>R. A. M.</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Caprioli</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Ramsey</surname>
<given-names>L. A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The protective effect of social reward on opioid and psychostimulant reward and relapse: behavior, pharmacology, and brain regions</article-title>. <source>J. Neurosci.</source> <volume>42</volume> (<issue>50</issue>), <fpage>9298</fpage>&#x2013;<lpage>9314</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0931-22.2022</pub-id>
</citation>
</ref>
<ref id="B135">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volkow</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Koob</surname>
<given-names>G. F.</given-names>
</name>
<name>
<surname>McLellan</surname>
<given-names>A. T.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Neurobiologic advances from the brain disease model of addiction</article-title>. <source>N. Engl. J. Med.</source> <volume>374</volume>, <fpage>363</fpage>&#x2013;<lpage>371</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1511480</pub-id>
</citation>
</ref>
<ref id="B136">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volkow</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Morales</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The brain on drugs: from reward to addiction</article-title>. <source>Cell</source> <volume>162</volume>, <fpage>712</fpage>&#x2013;<lpage>725</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.07.046</pub-id>
</citation>
</ref>
<ref id="B137">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>von dem Hagen</surname>
<given-names>E. A. H.</given-names>
</name>
<name>
<surname>Stoyanova</surname>
<given-names>R. S.</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Calder</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Reduced functional connectivity within and between &#x27;social&#x27; resting state networks in autism spectrum conditions</article-title>. <source>Soc. Cognitive Affect. Neurosci.</source> <volume>8</volume> (<issue>6</issue>), <fpage>694</fpage>&#x2013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1093/scan/nss053</pub-id>
</citation>
</ref>
<ref id="B138">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wahlstrom</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Tuliao</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>DiLillo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>McChargue</surname>
<given-names>D. E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Posttraumatic stress disorder symptoms, emotion dysregulation, and aggressive behavior among incarcerated methamphetamine users</article-title>. <source>J. Dual Diagn</source> <volume>11</volume> (<issue>2</issue>), <fpage>118</fpage>&#x2013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1080/15504263.2015.1025026</pub-id>
</citation>
</ref>
<ref id="B139">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wall</surname>
<given-names>V. L.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>Bland</surname>
<given-names>S. T.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Isolation rearing attenuates social interaction-induced expression of immediate early gene protein products in the medial prefrontal cortex of male and female rats</article-title>. <source>Physiol. Behav.</source> <volume>107</volume> (<issue>3</issue>), <fpage>440</fpage>&#x2013;<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2012.09.002</pub-id>
</citation>
</ref>
<ref id="B140">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Salience processing by glutamatergic neurons in the ventral pallidum</article-title>. <source>Sci. Bull.</source> <volume>65</volume>, <fpage>389</fpage>&#x2013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1016/j.scib.2019.11.029</pub-id>
</citation>
</ref>
<ref id="B141">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wardle</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>de Wit</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>MDMA alters emotional processing and facilitates positive social interaction</article-title>. <source>Psychopharmacol. Berl.</source> <volume>231</volume> (<issue>21</issue>), <fpage>4219</fpage>&#x2013;<lpage>4229</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-014-3570-x</pub-id>
</citation>
</ref>
<ref id="B142">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waxmonsky</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Waschbusch</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Babinski</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Humphrey</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Alfonso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Crum</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Does pharmacological treatment of ADHD in adults enhance parenting performance? Results of a double-blind randomized trial</article-title>. <source>Cns Drugs</source> <volume>28</volume>, <fpage>665</fpage>&#x2013;<lpage>677</lpage>. <pub-id pub-id-type="doi">10.1007/s40263-014-0165-3</pub-id>
</citation>
</ref>
<ref id="B143">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>West</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Carelli</surname>
<given-names>R. M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Nucleus accumbens core and shell differentially encode reward-associated cues after reinforcer devaluation</article-title>. <source>J. Neurosci.</source> <volume>36</volume>, <fpage>1128</fpage>&#x2013;<lpage>1139</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2976-15.2016</pub-id>
</citation>
</ref>
<ref id="B144">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitaker</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Degoulet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morikawa</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Social deprivation enhances VTA synaptic plasticity and drug-induced contextual learning</article-title>. <source>Neuron</source> <volume>77</volume>, <fpage>335</fpage>&#x2013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.11.022</pub-id>
</citation>
</ref>
<ref id="B145">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Rein</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications</article-title>. <source>Mol. Psychiatry</source> <volume>27</volume>, <fpage>445</fpage>&#x2013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-021-01092-3</pub-id>
</citation>
</ref>
<ref id="B146">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gobrogge</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kabbaj</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Amphetamine alters behavior and mesocorticolimbic dopamine receptor expression in the monogamous female prairie vole</article-title>. <source>Brain Res.</source> <volume>1367</volume>, <fpage>213</fpage>&#x2013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.109</pub-id>
</citation>
</ref>
<ref id="B147">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gobrogge</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Oxytocin reverses amphetamine-induced deficits in social bonding: evidence for an interaction with nucleus accumbens dopamine</article-title>. <source>J. Neurosci.</source> <volume>34</volume>, <fpage>8499</fpage>&#x2013;<lpage>8506</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4275-13.2014</pub-id>
</citation>
</ref>
<ref id="B148">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zahed</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Roozbakhsh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ashtiani</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Razjouyan</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The effect of long-acting methylphenidate and modafinil on attention and impulsivity of children with ADHD using a continuous performance test: a comparative study</article-title>. <source>Iran. J. Child Neurology</source> <volume>16</volume>, <fpage>67</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.22037/ijcn.v16i2.32541</pub-id>
</citation>
</ref>
<ref id="B149">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zell</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Steinkellner</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hollon</surname>
<given-names>N. G.</given-names>
</name>
<name>
<surname>Warlow</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Souter</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Faget</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>VTA glutamate neuron activity drives positive reinforcement absent dopamine Co-release</article-title>. <source>Neuron</source> <volume>107</volume>, <fpage>864</fpage>&#x2013;<lpage>873</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2020.06.011</pub-id>
</citation>
</ref>
<ref id="B150">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pittenger</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Calarco</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Mineur</surname>
<given-names>Y. S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Activity of a direct VTA to ventral pallidum GABA pathway encodes unconditioned reward value and sustains motivation for reward</article-title>. <source>Sci. Adv.</source> <volume>8</volume>, <fpage>eabm5217</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.abm5217</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>